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ABSTRACT
Drug-Related Mortality:
Postmortem Findings in
Clark County, Nevada
For 2005
By
Melanie Lee Gulmatico
Dr. Chad L. Cross, Examination Committee Chair
Associate Professor of Biostatistics
University o f Nevada, Las Vegas
Drugs, such as Cannibis, alcohol, cocaine and prescription medications can have
deleterious effects on the body. This thesis analyzed toxicology results in relation to
modes of death, and discusses who is at risk for deaths related to drug abuse. The modes
of death studied were homicides, suicides, accidents, and natural causes. Data (N=2426)
from Clark County, Nevada’s Coroner’s office were statistically analyzed using Chisquare analysis.
Major findings included relationships between drugs, ethnicity, age, gender and mode
o f death. Opioids and morphine derivatives were the most common drugs found in
Caucasians, females and those who died of natural and accident-related deaths.
Homicides were most commonly associated with ethanol and stimulants. The prevalence
o f ethanol was also most common within African Americans, Hispanics, Asians, males,
high school aged decedents and in suicides. The purpose of this study is to inform the
public and public health professionals of the associations found with drugs and death.
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CHAPTER 1

INTRODUCTION
Clark County, Nevada is home to Las Vegas, one of the fastest growing cities in the
nation (Research Applications, Inc., 2003). Along with this rapid population growth,
greater numbers of people in Clark County are dying every year. In 2005 over 10,000
deaths were reported to the Clark County Coroner’s Office (Clark County Coroner’s
Office). O f the deaths that were investigated, toxicological findings were recorded; they
include a variety of drugs commonly found on the streets, prescribed or accessible overthe-counter
Drugs can be either misused or abused. The difference between the two is that when
one misuses a drug, they are practicing inappropriate use of prescription or
nonprescription drugs (Levinthal, 2005). Such drugs are misused when dosages are
increased beyond the level prescribed, or when dangerously mixed with alcohol or other
drugs that affect the nervous system (Inaba & Cohen, 2004). The abuse of a drug applies
to when one utilizes a licit or illicit drug, “in ways that produce some form of physical,
mental, or social impairment” (Levinthal, 1999, p.6). Drugs which are commonly abused
involve not only common street drug such as cocaine or heroin, but also involve legal
psyehoactives such as caffeine, nicotine, alcohol and inhaled solvents (Inaba & Cohen,
2004). Prescription drugs are also being abused for purposes non-medicinal. Recreational
prescription drug use is often found in adolescents, teens, college students, adults and the
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elderly (Compton & Voikow, 2005; Kolek, 2006). Prescription drugs such as oxycodone,
hydrocodone, methadone and morphine are now being used recreationally. (Compton &
Volkow, 2005). Although illicit drugs such as cocaine and heroin are extremely
dangerous and potentially fatal, the danger of recreational misuse with prescription
medications can also lead to a deadly overdose.
Four different modes o f death, namely, natural, aeeident, suicides and homicides were
studied and the statistics of postmortem toxicological findings were examined. Ethnicity,
age and sex were also studied to see who was at greatest risk for drug-related deaths.
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CHAPTER 2

LITERATURE REVIEW
The drugs discussed in this section can be classified into five different levels or
schedules. Inaba & Cohen (2004) suggest that by controlling the manufacture, sale and
use of psychoactive drugs, the imports and exports of such drugs can be limited and
criminal penalties can be defined. Table 1 shows a list and description of the five drug
schedules.

Drug Categories
The drugs detected have been classified into 11 different categories by
The National Institute on Drug Abuse (NIDA): Antidepressants, prescription
medications, depressants, analgesics, dissociative anesthetics, cannabinoids, opioids and
morphine derivatives, stimulants, anabolic steroids, inhalants and over-the-counter
medications.
*Antidepressants
Over 17 million Americans a year are affected by depression, which results in
sadness, loss of pleasure and a decline in the capacity and willingness to enjoy life
(Levine, 1999; Levinthal, 2005). First generation antidepressants were found by accident
and were originally used for treatment of tuberculosis (Levinthal, 2005). After realizing
* See Appendix I for common names, brand names, street names and molecular
structures.
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patients were in better spirits, antidepressants started being prescribed for depression
(Inaba & Cohen, 2004; Levinthal, 2005). Owing to the fact that these drugs help people
feel good and overcome depression would lead one to believe that prescription overdose
in relation to these drugs may be problematic.

Table 1 Drug Schedules
Schedule

Description

I

High abuse potential and
supposedly no accepted
medical use

II

High abuse potential with
severe psychic or physical
dependence liability even
though there are medical
uses for the drugs

III

Less abuse potential and
include schedule II drugs
when used in compounds
with other drugs
Even less abuse potential

IV

Examples
Narcotics such as: Heroin,
LD, marijuana, peyote,
psilocybin, mescaline, and
MDMA
Narcotics such as: Cocaine,
methamphetamine, opium,
morphine, hydromorphone,
codeine, meperidine,
oxycodone, methylphenidate
(Ritalin®)
Prescription drugs such as:
Tylenol®, with codeine,
some barbiturate
compounds, and paregoric
Depressants such as: chloral
hydrate, meprobamate,
fenfluramine, diazepam
(Valium®), other
benzodiazepines and
phénobarbital
Over the counters such as:
Robitussin AC® (DXM),
Lomotil®

Very low abuse potential
because they contain
limited quantities of
narcotic and stimulant
drugs
Information for table adapted from Drug Enforcement Agency website; www.usdoj.gov
retrieved on August 25,2006
V
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Monoamine oxidase (MAO) is the key enzyme inhibited by first-generation
antidepressants (Levine, 1999; Levinthal, 2005). Although MAO inhibitors are
beneficial in treating depression, hindering this enzyme has detrimental effects on the
liver (Levinthal, 2005). MAO functions in the liver by helping break down the chemical
tyramine. If MAO is inhibited, high levels of tyramine will accumulate and potentially
increase the chance of having a stroke (Levinthal, 2005). Therefore, there are strict
dietary considerations when taking these medications (Kent, 2000).
Tricyclic antidepressants (TCAs) are another class of first-generation antidepressants
(Levine, 1999; Levinthal, 2005). Chemically, their structure contains three-rings, hence
the name tricyclic (Levinthal, 2005). They inhibit the reuptake of serotonin or
norepinepherine, or both, and have been found to be among the leading causes of drugrelated deaths in the world because of their high toxicity (Levine, 1999). However,
because TCAs do not inhibit MAO, they are generally safer than the first generation .
MAO inhibitors (Levinthal, 2005).
The pharmacologic action of second-generation antidepressants also inhibits the
reuptake of serotonin or norepinepherine or both neurotransmitters associated with mood
(Levine, 1999; Inaba & Cohen, 2004). These antidepressants increase the amount of
serotonin distributed throughout the nervous system, and hence are called serotonin
selective reuptake inhibitors (SSRIs) (Inaba & Cohen, 2004). Thus, by this action, they
correct the imbalance of serotonin. SSRIs are the most commonly prescribed group of
antidepressants and are also used in treating obsessive-compulsive disorder and bulimia
(Levine, 1999). SSRIs are more commonly prescribed than TCAs and have fewer
troublesome side effects. They also lack the cardiovascular toxicity associated with TCAs
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(Levine, 1999). The most recognized SSRI antidepressant is fluoxetine (brand name,
Prozac®). It was introduced in 1987 and aside from having few side effects it is also safe
for patients with cardiovascular problems (Levinthal, 2005). Thus, it can be used in place
of the tricyclic antidepressants mentioned above.
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) are a newer class of
antidepressants, which have lower side effects than SSRIs, yet are effieient in treating
mood disorders and generalized anxiety disorders (Mattia, Paoletti, Coluzzi, & Boanelli,
2002). The newest and most studied antidepressant of this class is Venlafaxine (brand
name, Effexor®), which is advantageous in its effectiveness in treating pain (Kent, 2000).
An interesting therapeutic result of Venlafaxine is that it has the capacity to act as either a
SSRI at low dosages or a TCA at high dosages (Mattia et al., 2002; Kent, 2000).
Depressants
Depressants (“downers”) affect individuals by reducing the activity of the brain, or by
inducing sedation, muscle relaxation and drowsiness (Levine, 1999; Inaba & Cohen,
2004). They are often used for those who feel immense stress and to help reduce anxieties
and problems encountered on a daily basis (Levinthal, 2005).
Barbiturates, benzodiazepines, meprobamate, buspirone, and zolpidem are a few of
the common central nervous system (CNS) depressants available today (Levine, 1999).
Barbiturates are one o f the oldest classes of depressants and were first synthesized in
1863 (Inaba & Cohen, 2004; Levine, 1999). They may be used during the induetion of
surgical anesthesia, to induce coma, as sedative-hypnotic agents, to control seizures or for

See Appendix II for common names, brand names, street names and molecular
structures.
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the relief of intracranial pressure in patients with head trauma (Inaba & Cohen, 2004;
Levine, 1999).
Benzodiazepines represent the other major class of CNS-depressant drugs. They
absorb slowly into the bloodstream, making their effects longer lasting than barbiturates
(Levinthal, 2005). Benzodiazepines also have a lower fat-solubility, greater watersolubility and are absorbed from the small intestine instead of the stomach like
barbiturates (Levinthal, 2005). They have been approved for use in people with
obsessive-compulsive disorders, as anxiolytics, muscle relaxants, anesthetic adjuncts, and
anticonvulsants (Levine, 1999). The safety of benzodiazepines is the major advantage of
these drugs. They have fewer side effects and lower withdrawal symptoms than
harbiturates; however, they are often abused concomitantly with methamphetamine,
cocaine or even heroin (Inaba & Cohen, 2004; Levine, 1999).
Studies have found that alcohol is one of the most commonly abused depressants, and
in fact it is estimated that annually over 2 million people die worldwide owing to alcohol
(Inaba & Cohen, 2004). Numerous physiological effects are associated with alcohol
consumption, such as gastric irritation, liver disease, cardiovascular effects, sleeping
problems and pregnancy defects (Levinthal, 2005). Not only does alcohol have
detrimental effects on the body, but it has been found that the relationship of alcohol,
drugs and violence has grown tremendously (Parker & Auerhahn, 1998). Studies have
shown that violent acts are overwhelmingly associated with alcohol use, more than any
other illieit or non-illicit substance (Parker & Auerhahn, 1998). Alcohol abuse and its
relation to violence, suicide and death will be discussed in greater detail in later sections.
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Assuming many people use depressants in order to run away from the many ordeals
and ehallenges life brings, would also lead one to believe that overdoses in these drugs
may potentially be a problem in relation to death.
^Stimulants
Stimulants are preseribed for disorders such as narcolepsy, attention defieit disorder
and obesity (Inaba & Cohen, 2004). However, the fact that stimulants trigger the
reward/reinforcement center of the brain makes addiction to theses drugs problematic
(Inaba & Cohen, 2004). Misuse of stimulants continues to be a problem, and in 2002 a
survey found that more than a third of the American population admitted to misusing
Attention-Defieit/Hyperaetiviy Disorder (ADHD) stimulants in their lifetime (Kroutil,
Van Brunt, Herman-Stahl, Heller, Bray, & Penne, 2006).
Unlike depressants, stimulants (“uppers”) increase the chemical and electrical activity
in the central nervous system (Inaba & Cohen, 2004). They make the user more alert,
cause feelings of intense pleasure, and feelings of increased energy after being taken
(Inaba & Cohen; Levine, 1999). The most commonly used stimulants are amphetamines
and methamphetamines (Levine, 1999). Manipulating the neurotransmitters epinephrine
and norepinephrine, stimulants force the release of these energy chemicals giving the
body bursts of energy (Inaba & Cohen, 2004).
Limited to disorders such as obesity, narcolepsy and attention deficit disorder,
prescription of psychostimulants can have serious side effects. Fenproporex, a drug used
for treatment of obesity, and modafmil, used for treatment of sleep and concentration
disorders, have been found to be extremely dangerous (Pelissier-Alicot, Piereecehi-Marti,
* See Appendix III for common names, brand names, street names and molecular
structures.
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Bartoli, Kuhlmann, Coiffait, Sanvosisin, Giocanti, & Leonetti, 2006). A study by PeliserAlicot et al. (2006) showed that fenproporex is incredibly addictive, and therefore it was
withdrawn from the market in 1999 because of lack of efficacy relating to obesity
management. However, this drug is still available on the Internet, thereby potentially
causing serious public health issues (Pelissier-Alicot et al., 2006). Modafinil was found to
have side effects including agitation, aggressive behavior and anorexia. As a central
nervous system stimulant, it has been used to treat ADHD in children 6 years of age and
older. Other side effects are insomnia and dependence therefore restricting Modafinil to a
maximum of 28 days (Pelissier-Alicot et al., 2006). Along with Modafinil, drugs such as
Ritalin, Dexedrine, Adderall and Cylert are all used for treatment of ADHD (Inaba &
Cohen, 2004). O f the children treated with these drugs, about 75% have effectively
controlled hyperactivity (Inaba & Cohen, 2004). Furthermore, easy accessibility of
prescription stimulants can lead to overdose or death if misused or abused.
Opioids and Morphine Derivatives
Opioids are alkaloid analgesics, which occur naturally in the opium poppy, Papaver
somniferum (Levine, 1999). The plant grows three to four feet high and its flowers are
about four or five inches in diameter. The flowers vary in color (white, pink, red or
purple) and the pods of these flowers contain opium (Levinthal, 2005). Clinically, opioids
are used in postoperative analgesia and also have therapeutic uses for pain management
in cancer and terminal illnesses (Levine, 1999).
Opium poppies were first used in Egypt and Greece, and then spread to Asia (Inaba &
Cohen, 2004). They were utilized for illness, as pleasure-inducing substances and as

See Appendix IV for common names, brand names, street names and molecular
structures.
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poisons (Inaba & Cohen, 2004). After opium use spread to the United States it was
utilized more by women than men because of the stigma towards women at the time
(Levinthal, 2005). Because alcohol use was not accepted with women, it was no surprise
to find men drinking alcohol in the saloon while women took opium at home during the
1940s (Levinthal, 2005). Opium smoking was introduced to the western US by Chinese,
who used it as a painkiller and for diarrhea treatment (Levinthal, 2005).
Morphine and codeine are extracts that come naturally from the unripe seed pod.
(Levine, 1999; Inaba & Cohen, 2004). Heroin, hydromorphone, hydrocodone and
oxycodone are semisynthetic opiates synthesized from morphine (Levine, 1999; Inaba &
Cohen, 2004). Methadone, meperidine and propoxyphene are fully synthetic opiate-like
drugs (Inaba & Cohen, 2004).
*Analgesics
Analgesics include nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin,
ibuprofen, naproxen sodium and acetaminophen. They are most commonly found in
groceries and pharmacies (Levinthal, 2005). Although NSAIDs are most commonly
found as over-the-counter medications, they are also prescribed for arthritic pain.
Celebrex is one popular brand of prescription NSAID (Levinthal, 2005). Analgesics,
commonly used by athletes, help reduce inflammation and deaden pain (Inaba & Cohen,
2004; Levinthal, 2005). Athletes often take analgesics to mask pain, which can
furthermore aggravate injury (Inaba & Cohen, 2004).
The analgesic compound salicylic acid was the first NSAID used to treat pain in the
19* century; however, it was extremely irritating to the digestive tract (Levinthal, 2005).

See Appendix V for common names, brand names, street names and molecular
structures
10
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Years later a chemist manipulated salicylic acid by adding an acetyl group in order to
lessen its toxicity. Because it was derived from spirea plants, salicylic acid was named
“aspirin.” It can be used to reduce inflammation, for mild pain such as headaches and
also to lower elevated body temperature (Levinthal, 2005). While opioids such as
morphine or hydrocodone work on the central nervous system, aspirin works by blocking
synthesis of hormones called prostaglandins via inhibition of cyclooxygenase (Hawkey,
1999; Levinthal, 2005). When injury occurs, prostaglandins encourage inflammation in
the joints and act on the hypothalamus of the brain, increasing body temperature. Thus,
aspirin is a helpful therapeutic drug in treating such ailments. Unfortunately,
physiological effects such as gastric bleeding, a reduction in blood clotting and Reye’s
syndrome may occur in children who are using aspirin for infections such as chicken pox
(Levinthal, 2005).
Ibuprofen is also used to lower body temperature, reduce pain or inflammation and
for menstrual cramps. As with aspirin, Ibuprofen has the same method of action in
blocking the production of prostaglandins (Levinthal, 2005). However, ibuprofen causes
less gastric irritation than aspirin, but may also cause kidney damage or failure
(Levinthal, 2005). Acetaminophen is also a popular over-the-counter analgesic, which is
used for pain and inflammation. It is less toxic on the stomach and does not interfere with
the clotting processes (Levinthal, 2005). A problem arising from usage of acetaminophen
is liver damage, espeeially if eombined with aleohol (Levinthal, 2005). After this was
discovered, the FDA recommended warnings on the labels to advise users of such
toxicity (Levinthal, 2005).

11
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Prescription Medications
Prescription drugs may be purchased after licensed physicians or other licensed health
professionals have certified utilization for a medical condition requiring such drugs
(Levinthal, 2005). In 2002 approximately $154.5 billion was spent on prescription
medications in America (Inaba & Cohen, 2004). The top ten leading brands of
prescription drugs include: Lipitor, Prevaeid, Prilocec, Zoeor, Celebrex, Zoloft, Paxil,
Zyprexa, Norvac and Nexium (Levinthal, 2005). After approval from the Food and Drug
Administration (FDA), prescription drugs are dispersed to a large population of patients.
Safety, effectiveness, and levels of dosage are finalized through the FDA (Levinthal,
2005). Although the FDA approves the distribution of prescription drugs, their safety is
only guaranteed if taken at recommended dosage (Levinthal, 2005). Thus, it is common
sense that the abuse o f prescription drugs may be dangerous.
**Over-the-Counter Drugs
Over-the-counter drugs are available to the public without a prescription and have
potential of misuse. Analgesics, sleep aids, and cough-and-cold remedies all can be
bought without the supervision of a physician (Levinthal, 2005). Corticosteroids are also
popular drugs found over-the-counter, and are used to control inflammation and pain
(Inaba & Cohen, 2004). Although easily accessible, NSAIDs can produce serious
problems if abused (Levinthal, 2005).
Over-the-counter drugs such as cough/cold preparations, analgesics and vitamins also
can be harmful to children (Chien, Marriott, Ashby, & Ozanne-Smith, 2003). The fact
* See Appendix VI for common names, brand names, street names and molecular
structures
"See Appendix VI for common names, brand names, street names and molecular
structures
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that they are widely available in homes, and stored in easily accessible cabinets and
cupboards, places children at a higher risk for overdose (Chien et al., 2003).
Dissociative Anesthetics
Dissociative anesthetics can be classified as hallucinogens, which produce feelings of
being dissociated or separated from oneself and the environment (Levinthal, 2005). The
most notorious o f this drug category is called phencyclidine (PCP) and causes not only
hallucinogenic effects, but also stimulant and depressant effects (Levinthal, 2005). A
common street name for PCP is “angel dust” because of the powdered form; liquid PCP
is sometimes mixed with marijuana (“sherm”) and smoked in order to enhance the effects
of marijuana (Levinthal, 2005, Inaba & Cohen, 2004). Initially phencyclidine was used
clinically as an anesthetic or analgesic in humans until adverse psychological reactions
were observed (Levine, 1999). It was also used as a tranquilizer for large-animals, yet the
legal manufacture o f PCP discontinued in 1979 (Levine, 1999). Behavioral and
psychological effects resulting from use of phencyelidine are perceptual distortions,
feelings of power and strength, disorientation, agitation, aggressive behavior and amnesia
(Levine, 1999; Levinthal, 2005). Other hallucinogenic drugs consist of LSD, psilocybin
“shrooms”, and peyote buds (Inaba & Cohen, 2004).
*Cannabinoids
Cannabinoids are found in numerous species of the Cannabis plant, the most eommon
of which is C. Sativa (Levine, 1999). They are found in the resin that aceumulates on the
leaves and stems o f this plant (Levinthal, 2005). It originated in Central Asia and was

See Appendix VII for common names, brand names, street names and molecular
structures
** See Appendix VIII for common names, brand names, street names and moleeular
structures
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used therapeutically for relief of pain, muscle spasms, convulsions, epilepsy, asthma, and
rheumatism (Levine, 1999). In 1910, cannabis was introduced to the United States and
continues to be the most commonly used drug (Levine, 1999). Interestingly, it is
classified by the Drug Enforcement Agency (DEA) as having no accepted medical uses
for any disease because other medications are available that are more effective (retrieved
from: http://www.usdoj.gov/dea/ongoing/marijuanap.html on August 2, 2006).
The primary psycho active agent in the Cannabis sativa plant is delta-9tetrahydrocannabinol (THC) (Levinthal, 2005; Levine, 1999). Several different
substances contain THC; these are marijuana, hashish, hash oil, and prescription Marinol,
which can produce hallucinogenic or a ‘pleasurable high’ depending on the dose (Levine,
1999). Marijuana is the most common psychoactive drug originating from the cannabis
plant, which contains different THC concentrations (Levinthal, 2005). Feelings of
euphoria and well being as well as sharpened sense of sight and sound are all
psychological and behavioral effects that have been reported with marijuana’s
intoxicating characteristics (Levinthal, 2005).
Anabolic Steroids
Anabolic steroids are used to promote the synthesis of proteins in the body, which in
turn increase muscular development and masculine characteristics (Inaba & Cohen, 2004;
Levinthal, 2005). The promotion of secondary male sexual characteristics is called an
androgenic effect while the acceleration o f muscle growth is an anabolic effect (Karch,
2002).

See Appendix IX for common names, brand names, street names and molecular
structures
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Before World War II, anabolic steroids were used to promote healing, speed recovery
time, and treat depression (Karch, 2002). They are popular with athletes because they are
believed to improve performance and strength (Karch, 2002). Derived from the male
hormone testosterone, steroids are clinically used to treat testosterone insufficiency,
osteoporosis and some breast cancers (Inaba & Cohen, 2004). Although they are
sometimes used to enhance personal appearance, when misused they can produce
undesirable effects such as feminization in males and masculinization in females (Inaba
& Cohen, 2005).
Inhalants
Inhalants consist o f volatile organic solvents, hydrocarbon gases, anesthetic gasses
and nitrites (Levine, 1999). Inhalants are sometimes classified as deliriants, producing
feelings of euphoria. They are similar to aleohol in that they depress the central nervous
system (Inaba & Cohen, 2004; Levine, 1999). They can be inhaled through the nose
and/or mouth, or even smoked after being heated or burned like tobacco and heroin
(Inaba & Cohen, 2004). Differences between inhalants and other psychoaetive drugs is
that they are quick acting, yet have intense effects and are readily available and
inexpensive (present in the home, garage and workplace). However, they do not get the
attention from media, educators or parents like illieit drugs such as phencyclidine (Inaba
& Cohen, 2004). Formaldehyde is often used as an inhalant for its depressant and
psychedelic effect. Marijuana joints are sometimes soaked in formaldehyde (“fi-ysticks”)
resulting in visual and auditory hallucinations, pain tolerance and feelings of being
invincible (Levinthal, 2005, NIDA, 2004). Unfortunately, inhalants can cause permanent
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damage to the liver, kidney, lungs and the CNS after just a short period of use (Inaba &
Cohen, 2004).
Other Compounds
In this study, other compounds consisted of substances such as caffeine, arsenic,
carbon monoxide, cyanide, mercury and lead. Although these compounds were found in
a select number of individuals, this paper focuses on the 11 drug categories discussed
above and will not go into great detail on the use of these compounds relating to death.

Socioeconomic Class, Age, Gender and Drug Abuse
Socioeconomic class, age and gender all play roles in the types of drugs that are
abused and potentially lead to fatalities. Blumstein (1995) suggests that there is a higher
correlation between the illicit drug market and rates of lethal violence among Blacks
compared to Whites. This conclusion was drawn because o f the fact that crack cocaine
market transactions were more common in impoverished, predominantly African
American communities (Blumstein, 1995). On the contrary the less dangerous and private
settings were correlated with a more expensive form of the drug (powder cocaine). These
transactions were more likely to occur in predominantly White eommunities.
Furthermore, Blumstein (1995) suggests that because the drug trade in predominantly
Black ghetto communities is highly correlated to a more hostile environment, it would be
reasonable to conclude that there is a link between drug-market activity and homicide
within these communities. However, Kilpatrick, Aciemo, Saunders, Resnick and Best
(2000), found that when controlling effects of demographics, victimization history and

* See Appendix X for common names, brand names, street names and molecular
structures
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familial substance use, Caucasian adolescents were between three to nine times more
likely to be at risk for substance abuse and dependence as opposed to African Americans.
A study conducted by Ousey and Lee (2004) found that there is a positive relationship
between Black cocaine/opiate distribution arrest rate and Black homicide rate. However,
the same relationship was found with the White drug market and White homicide rate.
Thus, it was found that cities having high arrest rates associated with an increasing drug
market also exhibit a high rate of homicide, regardless of ethnicity (Ousey & Lee, 2004).
The University of Maryland at College Park studied the risks associated with
adolescent substance abuse (Gottfredson & Koper, 1996). Findings suggested that social
integration, self-esteem, and self-efficacy all have low predictive validity (Gottfredson &
Koper, 1996). Positive peer influence does not affect black adolescents, yet decreases the
prevalence of drug use for Whites. Furthermore, drug use is more likely found in female
adolescents than for males, regardless of ethnicity. Peer influence predominantly affects
White adolescents and drug use is more strongly predicted for White male adolescents in
relation to rebellious behavior (Gottfredson & Koper, 1996).
In a study conducted by the National Household Survey of Drug Abuse in 1997,
marijuana use was highest among people between the ages of 18 and 24 at 22%, while
cocaine use was found in 4% of this group (Kilpatrick et al., 2000). Using data from the
National Health Interview Survey between 1987-1990 and the National Death Index data
through 1991, Kalian (1998) found that Males, Blacks, and Hispanics were identified as
high-risk subgroups for drug-related mortality. Males had a higher death rate than
females for fatalities owing to cocaine, or opiate abuse. Cocaine-related deaths were
higher for Black than Whites or Hispanics. Socioeconomic status also played a role in
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higher mortality rates for Blacks and Hispanics (Kalian, 1998). Violence has been
suggested to a play a role in not only adolescent, but also adult substance abuse as well
(Kilpatrick et al., 2000). Those substance abusers who were victimized at one point in
their lives were found to have started using drugs at a younger age than those who were
not victimized. Moreover, substance abuse has been found to be a way for adolescents
and adults to cope with stressors such as interpersonal aggression, whether it results from
sexual abuse or physical violence (Kilpatrick et al., 2000).

Specific Drugs and Fatalities
Research investigating the connection between the use of drugs and crime suggests
that there was a spike in violent crime when the craek-cocaine market emerged during the
1980s (Varano, McCluskey, Pat chin, & Bynun, 2004). Studies found a correlation
between poor-young-minority men and serious violent crimes during the late 1980s and
early 1990s (Varano et ah, 2004). In 1998 the Drug Abuse Monitoring Program (ADAM)
found that the majority of adult male arrestees were positive for cocaine use (Varano et
ah, 2004). Both marijuana and cocaine have been reported as drugs related to violence
(Varano et ah, 2004).
When looking at the involvement of drug circumstances in homicide events, research
shows that over half of all homicides potentially involve drugs (Varano et ah, 2004).
Research conducted on 800 homicide cases across the United States found that nearly a
quarter of these eases involved drugs (Varano et ah, 2004). Among homicide victims
killed in Bexar County, Texas 63% were positive for ethyl alcohol. Within these cases
alcohol and cocaine were found in abundance with alcohol being detected in more than

18

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

half of the victims (Garriott, DiMaio, & Rodriguez, 1986). People associated with the
drug market, whether it be abusing or selling, have been found to be involved in violent
disputes and homicides (Ousey & Lee, 2004).
A study conducted in Bexar County, Texas found a high correlation of drugs and/or
alcohol in homicide victims during the years of 1985, 1986, 1990 and 1991. The
concentrations ranged between 66% and 73% (Garriott, 1993). Although heroin
metabolites were detected in only a small amount of these cases, cocaine increased to
18.7% by 1991 from 1.6% o f cases in 1985. A metabolic byproduct of the combination of
cocaine and alcohol, coeaethylene, was measured as well during these years. It was found
that 58% of those who were positive for cocaine and alcohol also had concentration of
coeaethylene, which is possibly more toxic than cocaine alone (Garriott, 1993).
Furthermore, coeaethylene has been linked to increased rates of violent behavior (Inaba
& Cohen, 2004). Among other drugs found in homicide victims were phénobarbital,
benzodiazepines, diazepam, propoxyphene and antihistamines. Although found in fewer
numbers of eases, methadone and antidepressants were also identified in homicide
victims (Garriott, 1993).
Alcohol and Crime
Increases in aggression have been found with consumption of alcohol because it
interferes with the main inhibitory neurotransmitter, gamma amino butyric acid (GABA).
(Inaba &Cohen, 2004). Impulse control may also be inhibited due to decreases in the
levels of serotonin (Inaba &Cohen, 2004). When looking at violent crime, Inaba & Cohen
(2004) state that, “About one-fourth of the 11.1 million victims of violent crime report
that the offender had been drinking alcohol prior to committing the crime” (p. 207).
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Studies have found that when one is provoked and under the influence of alcohol,
aggression leading to violence may occur (Bushman, 1997; Lipsey, Wilson, Cohen, &
Derzon, 1997). It is known that alcohol causes reduced intellectual functioning, reduced
self-awareness, selective disinhibition, and inaccurate assessment of risks, it is highly
likely that violence may result when one is under the influence (Chermaek & Giancola
1997; Ito, Miller, Pollock, 1996; Parker & Auerhahn 1998). This may further lead to
one’s involvement in aggression and homicide.
Alcohol and Suicide
As alcoholics age, they are more likely to have social, health and interpersonal
problems. Thus, their risk for suicide increases (Inaba & Cohen, 2004). Furthermore,
along with increased age, suicide rates among alcoholics are twice as high than that of the
general population. The typical aleohol-suicide victim is a white, middle aged, male
(Inaba & Cohen, 2004). Depression, loss of job, living alone and poor social support are
other potential risk factors associated with suicide (Inaba & Cohen, 2004).
Overdose
As defined by the Office of National Statistics, drug related deaths may result from
long-term substance abusers, or occasional recreational users. Drugs involved may be
prescribed, controlled, or a mixture of both, and death may result from long-term use,
direct or long term effects. Furthermore, the deceased may die accidentally, through
suicide, or even homicide (Christophersen, Rooney, & Kelly, 1998).
Alcoholic overdose results from large amounts o f alcohol, such as a blood alcohol
content (BAC) at a level o f 0.40 (Inaba & Cohen, 2004). When this poisoning occurs,
depression o f the central nervous system results, which may furthermore lead to death
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(Inaba & Cohen, 2004). Although a 0.40 BAC has been noted as the threshold for alcohol
poisoning, levels at 0.20 or greater can depress respiration and lead to death in those with
low tolerance levels (Inaba & Cohen, 2004).
Opioid users, such as those who abuse heroin, are likely to experience toxic
overdoses (Inaba & Cohen, 2004). When looking at the number of people who use
oxycodone, oxycontin and other opioids, the risk of overdose owing to these types of
drugs is no surprise. Heroin overdose occurs when blood pressure drops and the lungs fill
with fluid, causing the victim to experience cardiac arrhythmias and convulsions, which
may lead to severe respiratory depression and death (Inaba & Cohen, 2004).

Motor Vehicle Fatalities
One of the major causes of mortality, motor vehicle accidents, kills around 300,000
people in the world every year. Alcohol, prescription drugs and illicit drugs can be
correlated to many o f these unfortunate motor vehicle fatalities (Kelly, Darke, & Ross,
2004).
Alcohol
Alcohol is the most common psyehoaetive substance found in the blood of victims
involved in motor vehicle crashes (Bates & Blakely, 1999). It reduces motor coordination
as well as alertness and depth perception. In order to drive safely, one must be alert and
able to make fast decisions in order to compensate for unexpected driving conditions and
situations. Alcohol, as a depressant drug, slows your brain and body, which can limit
awareness and coordination (Levine, 1999). Overconfidence is a common effect after
consumption of alcohol, which can alter judgment and driving skills (Levine, 1999).
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Among motor vehicle drivers killed in Bexar County, Texas, 55% of the drivers were
positive for ethyl alcohol (Garriott et al., 1986). Laboratory studies, simulator and driving
studies have all confirmed that performance after drinking alcohol increases deficits in
concentration, coordination, speed control, lane control, and brake reaction time (Kelly et
ah, 2004). Depending on their blood alcohol concentration, Christophersen et al. (1999)
found that accident risk can be anywhere from four to twelve times greater than those
who drive without being intoxicated.
Cannabis
Cannabis may affect short-term psyehomotor and cognitive effects in an individual
(Bates & Blakely, 1999). These effects not only alter perception and memory, but also
impair motor coordination tests (Inaba & Cohen, 2004). Psychomotor effects of Cannabis
use have been studied and it was found that following distance increased while driving
and that when Cannabis was mixed with alcohol, driving performance was affected
(Bates & Blakely, 1999). Cannabis is the second most frequent drug detected in motor
vehicle crashes (Bates & Blakely, 1999). In 1985, a study in Bexar County,Texas found
that approximately 50% of homicide and motor vehicle victims were tested positive for
the presence of eannabinoids (Garriott et al., 1986). When looking at epidemiological
studies examining the incidence of drug use in traffic collisions, between 2.7% and
13.9% of drivers tested positive for eannabinoids (Soderstrom, Dischinger, Kerns, &
Trifillis, 1995; Mercer & Jeffrey, 1995). On the contrary, although Cannabis users have
impairment while driving, experimental evidence has shown that they may modify their
driving behavior in order to compensate for impairment. Thus, they are less likely to take
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risks or drive at high speeds, which could possibly result in less fatalities or serious
injuries (Bates & Blakely, 1999).

Prescription and Illicit Drugs
In addition to alcohol, prescription depressants and painkillers may also affect driving
(Inaba & Cohen, 2004). Other drugs, which affect a person’s ability to drive include
cough, cold or allergy medications (Inaba & Cohen, 2004). Combining alcohol with such
drugs intensifies the effect and makes driving even more dangerous than either drug on
its own (Inaba & Cohen, 2004). After alcohol, cannabis, benzodiazepines and cocaine are
the next most commonly detected drugs in drivers involved in motor vehicle accidents
(Kelly et al., 2004). High levels of benzodiazepines were detected in many European
countries as well as the United States (Kelly et ah, 2004). Studies have found that
benzodiazepines, stimulants and opioids equivocally impair driving performance (Kelly
et ah, 2004). While the most common drugs found in motor vehicle fatalities in Canada
were eannabinoids, benzodiazepines, codeine, cocaine and barbiturates, in the United
States, Cannabis, cocaine, PCP and opiates were more common (MacDonald, 2002).
Woods, Katz, and Winger (1992) found that rates of benzodiazepines in arrested, injured
and fatally injured drivers ranged from 2% to 9.6% in America.
Of depressants, benzodiazepines are the most commonly studied in relation to
psyehomotor performance (Ferrara, 1987; Woods et ah, 1992). In Britain, people who
had prescriptions for sedatives such as benzodiazepines were almost five times more
likely to be involved in a serious road accident (Skegg, Richards, & Doll, 1979). In a
study conducted over 17 months in Belgium, urine tests were taken from injured drivers
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at emergency rooms. O f those tests, it was found that those who died as a result of motor
vehicle accidents were more likely to test positive for benzodiazepines, cannabis, or
methadone than any other drug (MacDonald, 2002). Laboratory tests have found that
benzodiazepines may be detrimental to people when trying to operate motor vehicles.
Inhibition o f visual and speed perception, information processing, coordination, reaction
time, memory and attention are all affected when one is taking such depressants (Kelly et
al., 2004).

Mortality Rates in the U.S. and Nevada
In Nevada, unintentional injuries were among the top three leading causes of death in
ages up to 54 years old while nationally, unintentional injuries were the leading cause of
death through age 34 (Research Applications, Inc., 2003). The top four mechanisms of
injury resulting in deaths in Nevada during the year 2001 were suicides, firearm related
deaths, motor vehicle crashes, and poisonings (including overdoses) (Research
Applications, Inc., 2003). The leading causes of death resulting from injury among
Nevada residents in 2001 are as follows: <1 (unintentional suffocation), 1-4 (Homicide
by other means), 5-9 (Unintentional Motor Vehicle Crashes traffic), 10-14 (Unintentional
Motor Vehicle Crashes Traffic), 15-24 (Unintentional Motor Vehicle Crashes Traffic, 2534 (Unintentional Motor Vehicle Crashes traffic), 35-44 (Accidental Poisoning or
Overdose), 45-54 (Accidental Poisoning or overdose), 55-64 (Unintentional Motor
Vehicle Crashes Traffic) and 65+ (Unintentional Motor Vehicle Crashes Traffic)
(Research Applications, Inc., 2003).
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During 2001, homicide in Nevada was the second most frequent cause of death for
people ages 15-24 and fourth for those between the ages of 25-34 (Research
Applications, Inc., 2003). Although homicides are most common among teenagers and
young adults, they occur in all age categories (Research Applications, Inc., 2003).
Furthermore, males are more likely to be victims and perpetrators in homicides, and
between the years o f 1976 and 1997, a study conducted by Fox (Bureau of Justice
Statistics, 1998) found that blacks are 7 times more likely than whites to be murdered.
In the United States, approximately 30,000 Americans commit suicide in any given
year (Wray, 2004). In 2000, Nevada’s residents compromised 19.1 suicides per 100,000.
These numbers were twice the national average of 10.7 (Wray, 2004). More than 400
people in Nevada die annually by suicide and of these people, males, residents’ aged 45
and over. Whites and Native Americans, and those who live in rural counties have higher
suicide rates (Research Applications, Inc., 2003). Between the years of 1952 and 1996,
adolescent suicide rates almost tripled in America and from 2000 to 2002, deaths of 219
Nevada teens (ages 15-19) resulted from homicide, accident or suicide (Wray, 2004).
Within the same time frame, an alarming 10.8% of middle school students and 8.8% of
high school students living in Nevada made an attempt at suicide (Wray, 2004).
In 2001, 29,368 people in Nevada were involved in motor vehicle crashes (including
pedestrians and bicyclists) and a total of 330 deaths resulted from these injuries
(Research Applications, Inc., 2003). When looking at gender differences in relation to
motor vehicle crashes, males were more likely than females to have injuries, whether
they be minor, moderate or fatal (Research Applications, Inc., 2003).
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Prescription Drug Abuse
Over the past 10 years, the abuse of prescription drugs has increased in the United
States (Compton & Volkow, 2005). Many problems arise when looking at the “epidemic”
of drug abuse such as addiction, unintentional drug overdose, suicide and crime.
Oxycontin, oxycodone, benzodiazepines, methadone and psychostimulants are a few of
the drugs discussed herein. Although used for medicinal purposes, these prescription
drugs can be extremely harmful to the body if abused illicitly. The public needs to be
aware of illicit prescription drug abuse in order to help prevent unintentional drug
overdose and hopefully find treatment programs for people who are at risk of dying from
a prescription drug overdose. Prescription drug abuse can be defined as; “any intentional
use of a medication with intoxicating properties outside of a physician’s prescription for a
bona fide medical condition, excluding accidental misuse” (Compton & Volkow, 2005, p.
4).
In 2003 approximately 15 million people ages 12 and over living in the United States
used a psychotherapeutic for non-medicinal purposes (Compton & Volkow, 2005).
Another study from the National Household Survey on Drug Abuse (NHSDA, 2001)
reported that Americans between the ages of 18 and 25 were found to have the highest
prevalence of illicit use of prescription drugs (Office of Applied Studies, 2002). The most
common sources of illicit prescription drugs contain opioid analgesics, stimulants,
anxiolytics/sedatives, and sleeping medications. These drugs were easily accessible
through peers, roommates, boyfriend/girlfriend, family members, and even drug dealers
(McCabe & Boyd, 2005).
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During the course of any given year, approximately 11 % of the United States adult
population has been found to have a substance abuse problem (Lester, Andreozzi, &
Appiah, 2004). Over-the-counter and prescribed medications are the most common drug
used by pregnant women. Owing to this fact, not only can they be harmful to the mother
using them, but may harm the unborn fetus as well. The placenta is important in
protecting the fetus from diffusion of foreign matter into fetal blood; however, it is quite
permeable to a diverse number o f drugs and toxins (Mooney, Boggess, Herbert, &
Layfield, 1998). Therefore, many prescription drugs may cross the placenta barrier and
harm the fetus as well. When studying a group of newborns, it was found that half had
NSAIDs in their first intestinal discharge (Inaba & Cohen, 2004). Drugs such as
benzodiazepines are incredibly difficult for a fetus to metabolize and can remain in their
systems for days leading to fetal depression and the possibility of death (Inaba & Cohen,
2004). This may occur via a phenomenon called ion trapping, which is due to differential
pH levels or through an increased number o f rapidly dividing cells present (Williams,
James, & Roberts, 2000).
Oxvcontin, Oxveodone and Other Opioids
One of the fastest growing eoneems for public health and non-medieal use and abuse
of prescription opioids is OxyContin and its generic competitor. Oxycodone (Bailey,
Barton, Lezotte, Lowensstein, & Dart, 2006). Approved in 1995 by the FDA, OxyContin
is an analgesic prescribed to individuals with moderate to severe pain having properties
similar to that of a narcotic (Cicero, Ineiardi, & Munoz, 2005). Far exceeding reports for
heroin misuse, the 2003 National Survey on Drug Use and Health (NSDUH) reported that
4.7 million Americans used prescription pain relievers illicitly within the past month
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(Bailey et al., 2006). When looking at the generic drug, oxycodone, it should be noted
that it is cheaper to purchase than OxyContin, making the abuse of this drug more
accessible to the public. Five years after its approval by the FDA, OxyContin abuse
arose and reports have shown that analgesic abuse can be classified as a national
epidemic (Cicero, 2005).
In 2002 prescription drugs such as hydroeodone and oxycodone were found to be the
most prevalent opioids resulting in trips to the emergency room, especially when used
concomitantly with other drugs (McCabe et ah, 2005). Showing an upward trend in the
use of medications illicitly, it has been found that over two million persons aged 12 and
older in the United States reported using opioid analgesics in 2000 for their first time
(Sung, Richter, Vaughan, Johnson, & Thom, 2005). In the mid-1980s it had only been
recorded that about 400,000 individuals experimented with such drugs for their first time.
Furthermore, between the years o f 1994 and 2001, the number of emergency room visits
increased over 300% for oxycodone and over a hundred percent for that of hydroeodone
(Sung et ah, 2005). This rising trend further confirms how opioid abuse is now becoming
a drug abuse epidemic.
Methadone and Bupronorphine
The opiate methadone has been designed to be a legal substitute for heroin. Its effects
are not as intense as the narcotic heroin, yet can be just as addicting (Inaba & Cohen,
2004). Although methadone maintenance has been used for heroin substance abusers
since 1994, the abuse of this drug has lead to alarming statistics. Between 1993 and 1994,
there was a 100% increase in methadone-related deaths in Scotland, whereas there was
only one reported death attributed to methadone in 1991 (Seymour, Black, Jay, Cooper,
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Weir, & Oliver, 2003). In North Carolina, between the years of 1997 and 2001, the
number of methadone- related deaths increased from 7 deaths to 58, a 729% increase. In
2001, a study found that o f methadone-related deaths, 21% percent of the decedents were
prescribed methadone for pain, another 8% was prescribed for an unstated reason and
19% of the methadone was obtained illegally (Sanford, 2002).
An alternative to methadone, buprenorphine, was approved by the FDA in 2002
(Jones, 2004). It has been described as a partial agonist for mu receptors in the brain,
meaning that in some ways it works as a pure opiate agonist such as methadone and
heroin, but in other ways is non-addictive and has relatively no clinical effects (Resniek,
Galanter, Pycha, Cohen, Grandion, & Flood, 1992).
Buprenorphine can be distinguished from other opioids such as methadone and heroin
because it interacts with the mu receptor, uniquely helping people overcome opioid
addiction (Jones, 2004). Unlike heroin and methadone, once buprenorphine is
discontinued, withdrawal symptoms are relatively mild (Resniek, 1992). Although more
expensive than methadone, buprenorphine has a lower rate of illicit use and has also been
found to be safer with low withdrawal symptoms after discontinuation (Jones, 2004). One
of buprenorphines beneficial characteristics involves the fact that since it has high affinity
for the mu receptor, it displaces other opioids (methadone and heroin) from binding to the
receptors. Thus, if it is given to an individual who has already taken an opioid such as
heroin, buprenorphine will compete with heroin and help with symptoms of withdrawal
(Jones, 2004).
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Problems With Prescription Drugs
Crime
Prescription drugs have been linked to aggression. Studies in rats have shown that
benzodiazepines may be linked to aggression at moderate dosages. If mixed with alcohol,
this type o f behavior may be increased (Pihl & Peterson, 1995). Benzodiazepines are
most commonly used with other drugs such as methamphetamines, cocaine and heroin
(Inaba & Cohen, 2004). The combination of these drugs, especially cocaine, puts users at
risk for violence. It has been found that pharmacological effects of cocaine induces
feelings of paranoia, which may lead to eocaine-assoeiated violence (Parker & Auerhahn,
1998). Thus, prescription drugs such as benzodiazepines can be linked to violence if used
not only alone, but also in conjunction with illicit drugs such as cocaine.
Suicide
Antidepressants have been found to increase the incidence of suicide. Such
prescription drugs include Prozac, Zoloft and Paxil. In the United Kingdom it was found
that people were more likely to commit suicide when first put on antidepressants (Jick,
Kaye, & Jick, 2004). The FDA has taken action by regulating these drugs with “black
box” labels warning people of the possibility of suicide. However, it is not certain if the
suicides were related to the drugs, or that of a mental illness (Prescriptions May Increase
Risk of Suicide. Retrieved April 8, 2006 from http://www.anxiety-and-depressionsolutions.eom/artieles/news/suieideriskl 02004.htm). Moreover, in Virginia,
antidepressants were the most common prescription drugs found in suicide related deaths
among adolescents and children (Vieweg, Linker, Anum, Turf, Pandurangi, Sood, Fierro,
& Fernandez, 2005).
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Benzodiazepines have been found to be involved in drug overdoses leading to death
within all age groups (Carlsten, Waem , Holmgren, & Allebeck, 2003). In younger and
middle-aged suicide eases, analgesics are most commonly used; however, there has been
an increase in suicides with benzodiazepines in the elderly population of Sweden over the
past two decades (Carlsten et ah, 2003).

Unintentional Drug Overdose
In North Carolina, the number of poisoning-related deaths has increased fastest in the
nation between the years of 1997 and 2001. More than half of the unintentional related
overdoses were due to legal or illegal drugs and have increased over a hundred percent
between these years (Sanford, 2002). In order to prevent unintentional drug-related
overdoses, counselors, drug rehabilitation centers, and family members of people with
substance abuse problems need to be aware of the statistics involved with drug overdoses.
When looking at the deaths caused by accidental drug overdoses, it was found that in
North Carolina, three quarters of the individuals who died had a history of “one or more
health problems at the time of their death, including substance abuse (53.8%), alcohol
abuse or alcoholism (23.8%), chronic pain (20.1%), or mental illness (20.4%)” (Sanford,
2002, p. 5). Furthermore, “the increase of single-drug deaths resulting from prescription
narcotics (eg. Oxycodone, methadone) in the five-year period increased from 32 to 96, a
300% increase” (Sanford, 2002, p. 7).

31

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Elderly and Preseription Drugs
The elderly represent 13% of the population, but consume 35% of prescription
medications in the United States (Hanlon, Sehmader, Boult, Artz, & Gross, 2002). The
most common of these prescriptions include those related to cardiovascular, analgesic
and central nervous system drugs (Hanlon et. al. 2002). A study conducted in North
Carolina found that of the following eight different drug classes: calcium channel
blockers (CCB); angiotensin-converting enzyme (ACE); histaminc2 receptor antagonists;
nonsteroidal anti-inflammatory drugs; benzodiazepines; antipsychotics and
antidepressants; benzodiazepines were found to be the most inappropriately prescribed
drugs (Hanlon et ah, 2002). Of the two different groups of participants studied in North
Carolina, 21% of one group (n=3,234) and 19.2% of the other group (n=2,508) were
inappropriately prescribed one or more elements from the eight different drug classes
(Hanlon et ah, 2002). Another study conducted in Canada found three categories of
inappropriate prescribing for the elderly:
“(1) the preseription introduces a substantial and clinically significant increase in the risk
of a serious adverse effect, (2) equally effective or more effective and less risky
alternative therapy is available for most patients, and (3) the practice is likely to occur
often enough that a change in practice could decrease morbidity in elderly people”
(McLeod, Huang, Tamblyn, & Gayton,1997, p. 386).
Benzodiazepines, trieyelic antidepressants and SSRls were common drugs found in
these three categories, and account for a disproportionate amount of prescribed
medications in the elderly (McLeod et ah 1997). Unfortunately, because the elderly suffer
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from more illnesses than the young, it is no surprise that they are prescribed a greater
majority o f medications and are at risk for inappropriate use.

Accessibility of Drugs
More and more people are being prescribed medications for a variety of ailments.
This places a diverse number of drugs on the shelves and in the medicine cabinets of
potential substance abusers (NIDA Community Drug Alert, 2005).
Street drugs such as amphetamines and methamphetamines have been a problem
since the early ‘70’s (Inaba & Cohen, 2004). Not only can substance abusers find cheap
forms of these drugs on the streets, but the fact that they can be easily manufactured in
homes or methamphetamine laboratories also explains why these types of drugs may be
easily accessible (Inaba & Cohen, 2004). Although the Controlled Substance Act of 1970
helped to regulate the purchase and prescription use of amphetamines, the illegal
manufacture of these drugs in the form of “crank” became a huge problem. Not only was
“crank” easily manufactured on the streets, but its purity also made it appealing to drug
substance abusers (Inaba & Cohen, 2004). Methamphetmaine can be manufactured easily
with pseudoephedrine. Some common over-the-counter brand names, which are
popularly used to convert pseudoephedrine to methamphetamine include, Advil Cold and
Sinus®, Claritin D®, and Sudafed® (Cline, 2005).
Prescribing drugs over the Internet is also a problem. This technology allows access
to preseription medications, which may explain why an increase in their abuse has
occurred (Henney & Shuren, 2000). Unfortunately, anyone who has a credit card can
access the Internet and purchase preseription drugs, without being monitored by a
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physician. Thus, easy access o f these drags via the Internet could explain the reason why
prescription drags are being abused throughout the country.
Accessibility of over-the-counter medications can also be a problem, especially
owing to the recent rise in methamphetamine laboratories (Cline, 2005). Over-the-counter
medications are not only easily accessible at grocery and convenience stores, but can be
abused for the psyehoaetive effects as well (NIDA Research Report Series, 2005).
Large cities such as New York, Dallas, Miami and Philadelphia commonly have high
accessibility of illicit drags and sales (Lurigio & Davis, 1992). Also, those who live in
lower socioeconomic class neighborhoods and inner cities are predisposed to problems
with drags and crime (Lurigio & Davis, 1992). Since the 1980’s violence and hard-drag
selling has increased among inner cities and drag-traffieking has been found to be higher
within inner cities rather than in the suburbs (Ensminger, Anthony, & McCord, 1997;
Johnson, Williams, Dei, & Sanabria, 1990). Between 1990 and 2000, Las Vegas was the
largest of the fast-growing cities (O ’Hare, 2001). Not only is Las Vegas at risk for high
drag trade on the streets, but is also a potential reservoir for illicit drag use and crime.
Based on review of the literature, several research questions became apparent.
Question 1: What are the major drugs associated with the four different modes of
death (suicide, homicide, accident, natural)?
Q2; Is there a relationship between age, gender and ethnicity with the types of drags
detected in the body after death?
Q3: Is there an association between prescription drags and mortality?
Several testable hypotheses were generated from these research questions and are
presented in the following chapter.
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CHAPTERS

OBJECTIVES, QUESTIONS, HYPOTHESES
This chapter presents objectives, questions and hypotheses. Objectives will be presented
first, followed with three questions and corresponding hypotheses.

Objectives
The following objectives were developed for this thesis.
•

This study will identify the most common drugs found in

postmortem toxicology screenings in Clark County, Nevada for 2005
• This study will evaluate the drugs found in toxicology screenings of decedents related
to age, gender and ethnicity
• This study will evaluate drugs found in toxicology screening related to accidents,
homicides, suicides and natural related deaths
• This study will examine pharmacotherapeutic interventions and determine what
prescription drugs are associated with mortalities
Questions and Hypotheses;
From the above objectives the following questions and hypotheses were developed for
this thesis.
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Question 1
What are the major drugs associated with the four different modes o f death (suicide,
homicide, accident, natural)?
Hypothesis 1(a): Those drugs that are easily accessible (e.g. Prescription drugs, over-thecounter medications) will be most common in postmortem toxicology screenings
Method: A contingency table will be used to examine the distribution of drugs
Hypothesis 1(b): Inexpensive drugs (e.g. preseription, over-the-counter medications) will
be highly prevalent in postmortem toxicology screenings
Method: A contingency table will be used to examine the distribution of drugs
Hypothesis 1(e): Alcohol will be most prevalent in motor vehicle fatalities
Method: A contingency table will be used to examine the distribution of drugs

Question 2
Is there a relationship between age, gender and ethnicity with the types of drugs
detected in the body after death?
Hypothesis 2(a): Teenagers will be more likely to have drugs such as cannabis and
alcohol
Method: A contingency table will be used to examine the distribution of drugs
Hypothesis 2(b): Males will be more likely to have a higher prevalence of drugs in their
bodies than females
Method: A contingency table will be used to examine the distribution of drugs
Hypothesis 2(c): There will be a difference in drug use among ethnicities
Method: A contingency table will be used to examine the distribution of drugs
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Hypothesis 2(d): Accidents and homicides will be one of the leading causes of deaths for
children/infants
Method: A contingency table will be used to analyze causes of death in
children/infants

Question 3
Is there an association between prescription drugs and mortality?
Hypothesis 3(a): Owing to easy accessibility in prescription drugs, there will be higher
rates of prescription drug related mortalities
Method: Analyses o f frequencies will be used to determine the distribution of drugs
Hypothesis 3(b): Depressants (benzodiazepines, barbiturates) will be the most commonly
found drugs in the elderly (aged 65+)
Method: Analyses o f frequencies will be used to determine the distribution of drugs
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CHAPTER 4

METHODOLOGY
This chapter discusses the methodology associated with postmortem toxicology
findings. Furthermore, the collection, categorization and statistical analyses of data will
be presented.

Data
The data analyzed were taken from toxicology reports from the Quest Diagnostics
Laboratory in Las Vegas, Nevada. Gas-Chromatography-Mass-Spectrometry was used to
determine what toxieologieal substances were found in postmortem specimens.
Specimens analyzed were blood, urine, liver, brain tissue, decomposition fluid and
vitreous fluid. An Institutional Review Board (IRB) exemption (0606-1993) was filed
with the UNLV Office for the Protection of Human Subjects and approved in order to
conduct research with the data obtained.
All data in the database represented counts; therefore all data were analyzed using
contingency tables. A ehi-square or equivalent statistic was calculated for each
contingency table.
After analyzing all data, some o f the results were broken down into two different
tables. One of the tables examined the results out of the total N (2426) while the other
table examined the data within age, drug, gender or ethnicity categories. This was done
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because different patterns were seen when examining the data within the total N as
opposed to a particular category.
Age Categories
The following age categories, taken from the National Survey on Drug Use and
Health, will be examined in order to find associations among age, fatalities and the types
of drugs found postmortem. The following age categories were used: gestation,
newborn/infant (<1 year), toddlers (1-4), children (5-11), middle and high school (12-17),
college age (18-25), young adulthood (26-34), career and family (35-49), middle age (5064) and retired (65+).
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CHAPTER 5

RESULTS
The following results will address each question and relevant hypotheses addressed in
this thesis. Appropriate chi-square distributions will be listed, as well as tables presenting
overall results for all statistical analyses conducted in this thesis.
Males, Caucasians and those 65 years and above represented the greatest number of
decedents. Accident-related deaths were highest of all modes of death (41.2%) with
natural related deaths (37.6%) consisting of the next largest number of deaths found.
Suicides consisted o f 13.4% o f all deaths, while homicides were at 7.8% (Tables 2 & 3).

^Table 2 Prevalence o f mode of death separated by gender (within total N).
MODE

Female
% (n)

Male
% (n)

Natural

12.3 (298)

25.3 (613)

Accident

13.9 (336)

27.4 (663)

Suicide

3.0 (72)

10.4 (252)

Homicide

1.6 (39)

6.2(151)

‘ A Chi-square analysis was used to determine the prevalence of mode of death separated
by gender within 2,426 decedents from the Clark County Coroner’s Office in 2005.
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Table 3 Prevalence o f gender, ethnicity, mode o f death and age.

Frequency
Category
*Pereent
Male
1679
69.2
Gender
Female
30.7
745
Caucasian
75.1
1823
African American
11.0
267
Hispanic
Ethnicity
11.1
269
Asian
67
2.8
Natural
913
37.6
Accident
41.2
999
Mode of Death
Suicide
13.4
324
Homicide
190
7.8
Gestation
.5
12
<1 (Newborn/Infant)
1.5
36
1-4 (Toddler)
1.2
30
5-11 (Childhood)
.5
11
12-17 (Middle and High
42
1.7
school)
18-24 (College)
224
Age
9.2
25-34 (Young Adulthood)
234
9.6
35-49 (Career and Family)
684
23.8
50-64 (Middle Age)
571
23.5
65+ (Retired)
684
28.2
*Total percent may not sum to 100% owing to non-reporting within certain variables
Variable

A more interesting result is found when examining death within the gender specific
death category. When examining the data this way, females represented a greater
majority of natural (40.0%) and accident-related deaths (45.1%) than males (Table 4).

Table 4 Prevalence of mode o f death found within gender specific categories.
MODE
Natural
Accident
Suicide
Homicide

Female n=745
% (n)
40.0 (298)
45.1 (336)
9.7 (72)
5.2 (39)

Male n=1679
% (n)
36.5 (613)
39.5 (663)
15.0(252)
9.0(151)

^ Prevalence of gender, ethnicity, mode of death and age categories found in 2,426
decedents from the Clark County Coroner’s Office in 2005.
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Question 1 addressed the major drugs found in four different modes of death (suicide,
homicide, accident, natural). O f all decedents, ethanol was the most common substance
found in natural-related deaths (7.1%) followed by opioids and morphine derivatives
(3.4%) and depressants (2.0%). In accident-related deaths, opioids and morphine

derivatives were highest (14.2%) followed by ethanol (9.7% ) and stimulants (9.4%).
Ethanol was found to be the most prevalent substance found in those who committed
suicide (4.3%) followed by opioids and morphine derivatives (2.8%) and depressants
(2.7%). In homicide-related deaths, ethanol (2.3%), stimulants (2.3%) and eannabinoids
(1.7%) were the most prevalent substances found. More prescription medications,

including antidepressants, depressants and opioid and morphine derivatives were found
than expected by chance (x^=71.458, p<.05) in accident and suicide-related deaths.
However, less over-the-counter medications were found than expected by chance in
accident, suicide, and homicide-related deaths (x^=12.366, p=.015). Furthermore, the
prevalence of alcohol in relation to suicides and homicides was found to be dependent
(X'=29.095, p<.001) (Table 5).
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Drug Categories/Mode of
Death
Anabolic Steroids

Natural
%(n)
0 (0 )

Accident
%(n)
0 (0 )

Suicide
%(n)
0(1)

Homicide
%(n)
0 (1 )

Analgesics

1.7(42)

2.3(55)

1.4 (33)

0.1 (2)

Antidepressants

0.6 (14)

1.8(43)

1.0(24)

0.0(1)

Cannabinoids

1.2(28)

3.8(92)

1.2(28)

1.7(41)

Depressants

2.0 (49)

7.0(170)

2.7(66)

0.5 (12)

0 (0 )

0 (1 )

0 (0 )

0.1 (2)

7.1 (173)

9.7 (235)

4.3 (104)

2.3 (57)

00%

0 (1 )

0 (0 )

0 (0 )

Opioids and Morphine
Derivatives

3.4(82)

14.2 (343)

2.8 (67)

0.5 (12)

Other Compounds

1.1 (29)

1.5(36)

0.5(11)

0 (1 )

Over-the-Counter
Medications

1.0(24)

0.8 (20)

0.7 (18)

0.2 (4)

Prescription Medications

1.7 (41)

5.2 (125)

1.3(32)

0.4 (9)

Stimulants

1.5 (36)

9.4 (227)

1.9(47)

2.3 (56)

Dissociative Anesthetics
Ethanol

Inhalants

^ Data from 2,426 decedents were statistically analyzed using chi-square analysis. The
prevalence of drugs present in decedents was determined within each mode of death.
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A more striking pattern is found when examining drugs found within the four modes
o f death. O f all natural deaths, ethanol (18.7%) was the most common substance found in
decedents followed by opioids and morphine derivatives (9.0%) and depressants (5.4%)
O f all accident-related deaths, opioids and morphine derivatives were most prevalent
(24.4%) followed by ethanol (23.7%) and stimulants (22.8%). O f all those who died of
suicides, ethanol (32.0%), opioids and morphine derivatives (21.0%) and depressants
(20.4%) were the most common substances found. O f all homicide-related deaths,
ethanol (29.3%) stimulants (28.8%) and cannabinoids (21.2%) were most prevalent.

Table 6 Prevalence o f mode o f death separated by drug categories (within mode of
death
Drug
Categories/Mode of
death
Anabolie Steroids
Analgesics
Antidepressants
Cannabinoids
Depressants
Dissociative
Anesthetics
Ethanol
Inhalants
Opioids and Morphine
Derivatives
Other Compounds
Over-the-Counter
Medieations
Prescription
Medications
Stimulants

Natural
n=925

Accident
n=1008

Suicide
n=328

Homicide
n=198

0 (0 )
4.5 (42)
1.5(14)
3.0(28)
5.4 (50)
0 (0 )

5.6(56)
/L2(42)
S fl(92)
17.2(173)
0.1 (1)

CX3(1)
10.4 (34)
7.3 (24)
8.5 (28)
20.4 (67)
(k0(0)

CX5(1)
1.0(2)
(X 5(l)
21.2(42)
6.6(13)
1.0(2)

18.7 (29)
0 (0 )
9.0(83)

23.7 (36)
0.1 (1)
34.4 (347)

32.0 (11)
00%
21.0(69)

:29.3 (1)
0 (0 )
6.6(13)

3.1(173)
2.6 (24)

3.6 (239)
2.0(20)

3.4(105)
5.8 (19)

0.5 (58)
2:0(4)

4.5 (42)

12.4 (125)

9.8 (32)

5.1 (10)

4.0 (37)

22.8(230)

14.3 (47)

28.8 (57)

Drugs were statistically analyzed using chi- square analysis. Each mode of death was
examined and the prevalence o f drugs present in decedents was determined.
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Of all decedents who died o f motor vehicle accidents (MVA), 25.5% had ethanol in
their toxicology results, 10.8% had cannabinoids and 6.9% had opioid and morphine
derivatives. More alcohol was found than expected by chance in all decedents who died
of motor-vehicle fatalities (x^=29.095, p<.001; Table 7). When examining all suiciderelated deaths, 2.1% of the decedents were found to have both ethanol and
opioid/morphine derivatives in their toxicology screening.

Table 7 Prevalence of drugs present in decedents who died of motor vehicle fatalities in
Clark County Nevada, 2005.
Motor Vehicle Accidents n=259
% (n)
0(0)

Drug Categories/Motor Vehicle
Accidents
Anabolic Steroids
Analgesics

2.7 (7)

Antidepressants

0.4 (1)

Cannabinoids

10.8 (28)

Depressants

5.0(13)

Dissociative Anesthetics

0(0)

Ethanol

25.5 (66)

Inhalants

0(0)

Opioids and Morphine Derivatives
Other Compounds

6.9 (18)
3.9(10)

Over-the-Counter Medications

E 5t%

Prescription Medications

4.6 (12)

Stimulants

10.4(27)

Question 2 addressed the relationship among age, gender and race with the types of
drugs detected in the body after death. After examining age and the type of substance
found in decedents, there were more cannabinoids than expected by chance within those
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between the ages o f 12 and 17 (x^=225.483, p<.001). This finding was also consistent
with those who were between 18 and 25 years of age. A greater number of college-age
decedents (18-25) were also found to have more alcohol in their toxicology screenings
than expected by chance (x^=l08.505, p<.001).
Of all decedents, stimulants were most commonly found within the gestation age
category (0.2%) while depressants and analgesics were most commonly found in those
less than one year of age. Ethanol (3.0%) was the most prevalent substance found in
college age decedents followed by cannabinoids (2.5%) and stimulants (2.0%). Ethanol
(3.1%), opioids and morphine derivatives (2.9%) and stimulants (2.7%) were most
common in young adulthood. Opioids and morphine derivatives (7.5%) represented the
majority of substances found in those within the career and family age group followed by
ethanol (6.7%) and stimulants (6.6%). Furthermore, ethanol was the most common
substance found in middle age decedents (6.4%) and those who were 65 years of age and
older (3.7%) (Table 8).
Of all antidepressants, prescription medications, depressants, analgesics,
cannabinoids, opioid and morphine derivatives, stimulants, and ethanol, decedents within
the career and family age group (aged 35-49) represented the highest number of these
substances. O f all dissociative anesthetics (n=3), those in young adulthood represented
the highest majority o f decedents. When examining all over-the-counter medications
(n=66) found in decedents, those who were between the ages of 50 and 64 had the highest
prevalence of these substances (34.8%) (Table 9).
Furthermore, it is important to examine drug prevalence within specific age
categories. O f all decedents who were between 12 and 17 years of age and those within

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

college years (18-25), ethanol and cannabinoids represented the majority of substanees.
Ethanol and opioids and morphine derivatives were most common among all those who
were 26 years or older. Ethanol represented the majority of substances found within the
elderly population (65+) followed by opioid and morphine derivatives and depressants.
Although depressants were not the most common substances detected, they did represent
5.8% of the drugs found within those who were o f 65 years of age and older. (Table 10).
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18-25
(College)
% (n )

2634
(Young
Adulthood)
% (n )

35-49
(Career
and
Family)
% (n )

50-60
(Middle
Age)
% (n )

65+
(Retired)
% (n )

Anabolic
Steroids

0 (0 )

0^0

om)

0^0

C)(0)

0(%

0 4 (0

0 (0 )

OW)

o#0

Analgesics

0 (0 )

03(4)

04(2)

o#0

0.1(2)

C204

0.7(17)

2.0 (48)

E 4CD )

0.9(21)

Anti
depressants

0 (0 )

0^0

0^0

0^0

0 (0

0 4 D)

03(5)

1.4(35)

1.1 (27)

0.4 (10)

Cannabinoids

0 (0 )

OQ)

0 (0 )

0.3(8)

2.5 (60)

1.6(38)

2.5 (60)

0.9 (21)

0 (0 )

O #0
0 3(4)

OQ)

0 4 CO

0 4 (2)

0.8 (20)

1.8 (43)

4.4 (106)

3.3 (80)

04 (0
1.7(40)

Depressants
Dissociative
Anesthetics
Ethanol

0 (0 )

om )

0^0

0^0

0^0

0 (0

0.1(2)

0 (0 )

0 (0 )

0(0)

0 (1 )

0 (1 )

0^0

0 (0

0.4 (10)

3.0 (73)

3.1 (75)

6.7 (162)

6.4 (155)

3.7 (89)

Inhalants

0 (0 )

0^0

0(0 )

0^0

0^0

0 (0

0 (0 )

o#9

0^)

0(0)

Opioids and
Morphine
Derivatives

0 (1 )

0.1(2)

0(1)

0^0

0 4 (3)

1.5(37)

2.9 (71)

7.5 (181)

5.7(138)

2.9 (70)

0.0(1)

0.0(1)

0^0

0 (0 )

0.0(1)

C3#0

0.3(8)

1.2(28)

0.7 (18)

0 3 (12)

Over-theCounter
Medications

0^0

0.1(2)

0 (0 )

0^0

0 (0

C2#)

03(6)

0.6 (15)

&9CM)

0.5(13)

Prescription
Medications

om)

0.1(3)

OTHQ

0.0(1)

0.1(3)

0.6 (15)

1.0(25)

3.5(85)

2.0 (48)

1.1 (27)

0.2 (5)

0.1(3)

o(H

0 (0 )

0 (0 )

2.0 (48)

2.7 (66)

64) (161)

28##)

0.5 (13)

Other Compounds

■CDD
I
(/)
W

12-17
(Middle
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school)
% (n )

Stimulants

^ Data from 2426 decedents were taken from the Clark County Coroner’s Office in 2005. The prevalence of drugs found in decedents
was examined using chi-square analysis.
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Table 9 Prevalence of drug categories separated by age (within drug categories)
Drug
Categories/Age

Anabolic
Steroids n=2
Analgesics n=132
Anti-depressants
n=81
Cannabinoids
n=189
Depressants n=297
Dissociative
Anesthetics n=3
Ethanol n=569

1-4
(Toddler)
%(n)

5-11
(Childhood)
%(n)

0 (0 )

<1 yr
(newborn
or infant)
%(n)
o#o

0#)

0#9

12-17
(Middle
and High
school)
% (0
0 (0 )

0 (0 )
0 (0 )

3 0 (4 )
OQ)

1.5(2)
o#o

o#9
00)

0(Q

o#o

OQ)

0 (0 )

1.3(4)

0 (0 )
0.2(1)

Gestation
%(n)

35-49
(Career
and
Family)
% (0
00)

50-60
(Middle
Age)
%(n)
00)

65+
(Retired)
%(n)

0(0

26-34
(Young
Adulthood)
%(n)
100.0 (2)

1.5(2)
1.2(1)

3.8(5)
3.7(3)

12.9(17)
6.2(5)

36.4 (48)
43.2 (35)

25.0 (33)
33.3 (27)

15.9 (21)
12.3 (10)

00)

4.2(8)

31.7 (60)

20.1 (38)

31.7(60)

11.1 (21)

14(2)

OQ)

0.7(2)

0:7(2)

6.7 (20)

14.5 (43)

35.7 (106)

26.9 (80)

13.5 (40)

o#o

OQ)

00)

0 (0 )

3 3 3 (1)

6C 7 (2)

00)

0(0

00)

0.2(1)

0.2(1)

1.8 (10)

12.9(73)

13.2(75)

2& 6(1&0

27.3 (155)

15.7 (89)

00)

0 (0 )

100.0(1)

00)

00)

0 0)

0 0)

1&35
(College)
%(n)

0 0)

0 (0 )

o#9

o#o
om)

Opioids and
Morphine
Derivatives n=504

0.2(1)

0.4(2)

0.2(1)

00)

0.6(3)

7.3 (37)

114.1 (71)

35.9 (181)

27.4 (138)

13.9 (70)

Other Compounds
n=77
Over the
Counters
Medications n=66
Prescription
Medications n=207

1.3(1)

13(1)

o#0

OQ)

1.3(1)

10.4(8)

10.4 (8)

36.4 (28)

23.4(18)

15.6 (12)

0 (0 )

3.0(2)

OQ)

00)

1.5(1)

9 4 (0

9 4 (0

22.7(15)

34.8 (23)

19.7(13)

0 (0 )

1.4(3)

0.0(0)

0.5(1)

1.4(3)

7.2(15)

12.1 (25)

41.1 (87)

23.2 (48)

13.0 (27)

Stimulants n=366

1.4(5)

0.8(3)

0 (1 )

00)

0 (0 )

13.2 (48)

18.1 (66)

44.1 (161)

18.6 (68)

3.6 (13)

Inhalants n=l

Chi-square analysis was conducted on data from the Clark County Coroner’s Office, 2005. Of all drug categories, the prevalence of
drugs was found separated by age.
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^Table 10 Prevalence of drug categories separated by age (within age categories)
Drug
Categories/

CD

Gestation
n=12

<1 yr
(newborn
or infant)
n=36
% (n)

1-4
(Toddler)
n=30

5-11
(Childhood)
n = ll

%(n)

%(n)

12-17
(Middle and
High school)
n=42

18-25

26-34

35-49

50-64

(College)
n=224

(Young
Adulthood)

(M iddle
A ge) n=571

%(n)

n=234

(Career and
Family)
n=578

% (n)

n -684
%(n)

% (n)
0 (0 )

0 (0 )

0 (0 )

7.3 (17)

8.3 (48)

5 3 (3 3 )

3.1(21)

1.3(3)

2.1(5)

64 05)

4.7 (27)

1.5 (10)

19.0 (8)

26.8 (60)

16.2(38)

10.4 (60)

3.7(21)

C3 0 )

1 8 3 (2 )

4 .8 (2 )

8.9 (20)

18/1(43)

183 (106)

14.0 (80)

^8 0 0

0 (0

0 (0 )

0 (0 )

0 .4(1)

0.9(2)

0 (0 )

0 (0

0 (0

2 .8 (1 )
0 (0 )

0 (0
0 (0 )

9.1(1)
0 (0 )

23.8 (10)
0 (0 )

32.6 (73)
0 .4(1)

32.1 (75)
00)

28.0(162)
00)

274 0 5 5 )
00)

13.0 (89)
0 (0

8 3 (1 )

5 .6 ( 0

3.3(1)

0 (0 )

7 .1(3)

16.5 (37)

30.3 (71)

3 1 4 (1 8 1 )

24.2 (138)

10.2 (70)

Other
Compounds

8 3 (1)

2 .8 (1 )

0 (0 )

0 (0 )

2 .4(1)

3 .6(8)

34(0

4.8 (28)

3.2 (18)

1.8(12)

Over the
Counter
Medications
Prescription
Medications

00)

^60)

0 (0 )

0 (0 )

2 .4 (1 )

2 3 (0

2 5 (6 )

2.6(15)

4.0 (23)

1.9(13)

00)

&3 0 )

0 (0 )

9.1 (1)

7 .1 (3 )

6.7 (15)

10.7 (25)

14.7 (85)

8.4 (48)

2 9 (2 7 )

4 1.7(5)

8 .3 (3 )

3.3(1)

0 (0 )

0 (0 )

21.4 (48)

28.2 (66)

27.9(161)

11.9 (68)

E 9(13)

%(n)

8

Age
00)

0 (0 )

0 (0 )

0 (0 )

% (n)
0 (0 )

0 (0 )

0.9 (2)

3

Anabolic
Steroids
Analgesics

00)

11.1(4)

6.7(2)

0 (0 )

4 .8 (2 )

2 .2 (5 )

Anti
depressants

00)

0 (0

0 (0

0 (0 )

2 .4(1)

CD

Cannabinoids

00)

0 (0

0 (0

0 (0 )

CD

Depressants

00)

11.1(4)

0 (0 )

D issociative
Anesthetics

00)

0 (0

8.3 (1)
00)

Opioids and
M oiphine
Derivatives

5
C5-

65+
(Retired)

% (n)

CD

C

3.
3
"

■O

I

C

a
o

3

■O
S
&
o

c

C/)

(g

o"
3

O

Ethanol
Inhalants

Stimulants

’ Data from the Clark County Coroner’s office in 2005 were analyzed statistically using chi-square analysis. Of all decedents who
were categorized into different age categories, the prevalence of drugs present was reported.

Of all decedents, opioids and morphine derivatives were the most commonly found
substances found in females (7.8%) followed by depressants (4.9%) and ethanol (4.0%).
Males were most likely to have ethanol in their toxicology screenings (19.5%) followed
by opioids and morphine derivatives (13.0%) and stimulants (11.6%). More prescription
medications were found than expected by chance in females, whereas less were found in
males (%^=18.600, p<.001; Table 11).

^Table 11 Prevalence o f drug categories separated by gender (within total N)
Drugs/Gender
Anabolic Steroids

Female
%(n)
0 (0 )

Male
%(n)
0 0 (2 )

Analgesics

2.1(52)

3.3 (80)

Antidepressants

1 6 (3 8 )

1.8(43)

Cannabinoids

1.2(30)

(x6(159)

4L9(118)

7.4(179)

0 (0 )

0.1 (3)

Ethanol

4.0 (96)

19.5(473)

Inhalants

0 (0 )

0(1)

Opioids and Morphine
Derivatives
Other Compounds

7.8 (190)

13.0(313)

0.9 (21)

2.3 (56)

Over-the-Counter
Medications
Prescription Medications

0.9 (23)

1.8(43)

3.8(91)

4.8(116)

Stimulants

3.5(85)

11.6(281)

Depressants
Dissoeiative Anesthetics

* Data from 2426 deeedents were taken from the Clark County Coroner’s office in 2005.
Chi-square analysis was used to statistically analyze the prevalence of drugs present in
decedents who were eategorized by gender.
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Of all drug categories, males outnumbered females in the prevalence of substances
found in toxicology screenings (Table 12).

^Table 12 Prevalence o f drug eategories separated by gender (within drug categories)
Drugs/Gender
Female
Male
%(n)
%(n)
Anabolic
Steroids (n=2)

0 (0 )

100.0(2)

Analgesics (n=132)

39.4 (52)

60.6 (80)

Antidepressants (n=81)

46.9 (38)

53.1 (43)

Cannabinoids (n=189)

15.9(30)

84.1 (159)

39.7(118)

(%l.3(179)

0 (0 )

100.0 (3)

Ethanol (n=569)

16.9 (96)

83.1 (473)

Inhalants (n=l)

0 (0 )

100.0(1)

37.7(190)

6 2 0 (3 1 4 )

27.3 (21)

72.7 (56)

Over-the-Counter
Medications (n=66)

3Afr(2%

65.2 (43)

Prescription
Medications (n=207)

44.0 (91)

56.0(116)

Stimulants (n=366)

23.2 (85)

76.8(281)

Depressants (n=297)
Dissociative
Anesthetics (n=3)

Opioids and
Morphine
Derivatives (n=504)
Other Compounds (n=77)

^ Data taken from the Clark County Coroner’s Office from 2005 were analyzed
statistieally. Eaeh drug category was examined and the prevalenee o f drugs separated by
gender was determined using ehi-square analysis.
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O f all female decedents, 25.5% had opioids and morphine derivatives in their
toxicology screenings followed by depressants (15.8%) and ethanol (12.9%). O f all male
decedents, ethanol (28.2%) represented the majority of all substances followed by 18.5%
of opioid and morphine derivatives and 16.7% of stimulants (Table 13).

*°Table 13 Prevalence of drug categories separated by gender (within gender)
Drugs/Gender

Female n=707
% (n)
0(0)

Male n=1636
% (n)
0 0 (2 )

Analgesics

7.0 (52)

/L8(80)

Antidepressants

5.1 (38)

2.6 (43)

Cannabinoids

4.0 (30)

9.5(159)

15.8(118)

10.7 (179)

0(0)

0.2 (3)

Ethanol

12.9 (96)

28.2(473)

Inhalants

0(0)

0.1(1)

25.5(190)

18.7(314)

2.8 (21)

3.3 (56)

Anabolie Steroids

Depressants
Dissociative Anesthetics

Opioids and Morphine
Derivatives
Other Compounds
Over-the-Counter
Medications
Prescription Medications

3.1(23)

2.6 (43)

12.2 (91)

6.9(116)

Stimulants

11.4 (85)

16.7 (281)

Data taken from the Clark County Coroner’s Office from 2005 were analyzed
statistically. Each gender category was examined and the prevalence of drugs was
determined using chi-square analysis.
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Ethanol (2.3%), stimulants (2.1%) and cannabinoids (1.4%) were the most common
substances found in African Americans. Opioids and morphine derivatives (18.0%) were
most common in Caucasians followed by ethanol (17.8%) and depressants (10.8%).
Ethanol .was most commonly found in Hispanics and Asians (Tables 14 & 15).

11
Table 14 Prevalence of drug categories separated by ethnicity (within total N)
African
American
% (n)
0(0)

Caucasian
% (n)

Asian
% (n)

Hispanic
% (n)

0 0 (2 )

0(0)

0(0)

Analgesics

0.5 (12)

4.2 (102)

0 0 (2 )

0.7(16)

Anti-depressants

Cf3(8)

2.7(66)

0(1)

2(6)

Cannabinoids

1/4(35)

5.5(133)

0(0)

0.9 (21)

Depressants

0.7 (16)

10.8(262)

0.2(4)

0.6(15)

Dissociative
Anesthetics
Ethanol

0.1 (2)

0(0)

0(0)

0(1)

2.3 (57)

17.8(432)

0.4 (9)

2.9 (71)

0(0)

0(0)

0(0)

0(1)

1.4 (33)

18 0(436)

(X3(8)

1.1(27)

0.5 (11)

2.5(60)

0(0)

(X2(6)

0.3 (8)

2.1 (50)

0(1)

0.3(7)

.7(17)

7.0(171)

.2t%

.6(15)

2.1 (50)

10.7 (260)

0(1)

2.3(55)

Drug
Categories/Ethnicity
Anabolic Steroids

Inhalants
Opioids and Morphine
Derivatives
Other Compounds
Over the Counter
Medications
Prescription
Medications
Stimulants

” Data from 2426 decedents were taken from the Clark County Coroner’s Office in 2005.
A chi-square analysis was used to statistically analyze the prevalence of drugs present in
decedents who were separated by ethnicity.
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12 .

Table 15 Prevalence o f drug categories separated by ethnicity (within ethnicity)
Drug Categories/Ethnicity
African
Caucasian
Asian n=67
Hispanic
American
n=1823
%(n)
n=269
n=267
%(n)
%(n)
%(n)
Anabolic Steroids
0 (0 )
0.1 (2)
0 (0 )
0 (0 )

Analgesics

4.5 (12)

5.6 (102)

3.0 (2)

5.9 (16)

Anti-depressants

3.0 (8)

3.6 (66)

1.5 (1)

2.2 (6)

Cannabinoids

13.1 (35)

7.3 (133)

0 (0 )

7.8 (21)

Depressants

6.0(16)

14.4 (262)

6.0 (4)

5.6(15)

Dissociative Anestheties

0.7 (2)

0 (0 )

0 (0 )

0.4 (1)

21.3 (57)

23.7 (432)

13.4 (9)

26.4 (71)

0 (0 )

0 (0 )

0 (0 )

0.4(1)

Opioids and Morphine
Derivatives

12.4 (33)

23.9 (436)

11.9 (8)

10.0(27)

Other Compounds

4.1 (11)

3.3 (60)

0 (0 )

2.2 (6)

Over-the-Counter
Medications

3.0 (8)

2.7 (50)

1.5(1)

2.6(7)

Prescription
Medications

6.4 (17)

9.4(171)

6.0 (4)

5.6(15)

Stimulants

18.7 (50)

14.3 (260)

1.5 (1)

20.4 (55)

Ethanol
Inhalants

Data taken from the Clark County Coroner’s Office from 2005 were analyzed
statistieally. Each ethnicity category was examined and the prevalenee of drugs was
determined using chi-square analysis.
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As hypothesized, accident and homicide-related deaths were most common among
toddlers (aged 1-4) and those in childhood years (aged 5-11). Furthermore, more accident
and homicide related deaths were found than expected by chance (x^=637.484, p<.001).
Of the 30 children that died between the ages of 1 and 4, over half of them died of
aceidents, and nearly a quarter of them died as a result of homicide. Approximately 64%
of those within childhood ages (aged 5-11) died from accidents (45%-motor vehicle
accidents), while 27.3% died as a result of homicide (Table 16)
Those who were 65 years of age and older represented the majority of all naturalrelated deaths followed by those who were in middle age (aged 50-64) and those within
eareer and family ages (aged 35-49). Accident-related deaths and suicides were highest
among those between 35 and 49 years of age, and homicides were highest among those
between the ages of 18 and 26 (Table 17 & 18). Natural-related deaths were highest
among those in gestation and who were newborn or infant. Of all deeedents who were
toddlers (aged 1-4), aecident-related deaths were highest (56.7%) followed by homicides
(23.3%). Of all decedents who were between 12 and 49 years of age, aceident-related
deaths were highest while natural-related deaths were most common among all decedents
who were 50 years of age and older (Tables 16 & 17).

56

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Age/Mode o f Death

Natural
%(n)

Accident
%(n)

Suicide
%(n)

Homicide
%(n)

Gestation

0.3 (7)

0.2 (5)

0 (0 )

0 (0 )

<1 (Newborn/infant)

0.9 (29)

0.4 (9)

0 (0 )

0.2 (6)

1-4 (Toddler)

0.2 (6)

0.7 (17)

0 (0 )

0.3 (7)

0 (1 )

0.3 (7)

0 (0 )

0.1 (3)

12-17 (Middle and
High school)

0.2 (5)

1.1 (26)

0.4 (9)

0.1 (2)

18-25 (College)

0.7(16)

4.7(113)

1.6 (39)

2.3 (56)

26-34 (Young
Adulthood)

1.2(29)

4.7(114)

2.1 (50)

1.7(41)

35-49 (Career and
Family)

6.1 (148)

12.0 (289)

3.7 (90)

2.1 (51)

50-64 (Middle Age)

11.0 (267)

8.6 (209)

3.3 (79)

0.7 (16)

65+ (Retired)

17.1 (413)

8.6 (208)

2.3 (56)

0.3 (7)

5-11 (Childhood)

Data from 2426 decedents were taken from the Clark County Coroner’s Office in 2005.
A chi-square analysis was used to statistically analyze the age categories of decedents
separated by mode of death.
57

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14,

Table 17 Prevalence o f age separated by mode o f death (within age)

Age/Mode of Death

Natural
%(n)

Accident
%(n)

Suicide
%(n)

Homicide
%(n)

Gestation n=12

58.3 (7)

41.7(5)

0 (0 )

0 (0 )

<1 (Newbom/infant) n=36

58.3 (21)

25.0 (9)

0 (0 )

16.7(6)

1-4 (Toddler) n=30

20.0(6)

56.7 (17)

0 (0 )

23.3 (7)

5-11 (Childhood) n=l 1

9.1 (1)

63.6 (7)

0 (0 )

27.3 (3)

12-17 (Middle and High
school) n=42

11.9(5)

61.9(26)

21.4 (9)

4.8 (2)

18-25 (College) n=224

7.1 (16)

50.4(113)

17.4 (39)

25.0 (56)

26-34 (Young Adulthood)
n=234

12.4 (29)

48.7(114)

21.4 (50)

17.5(41)

35-49 (Career and
Family) n=578

25.6 (148)

50.0 (239)

15.6 (90)

8.8 (51)

50-64 (Middle Age)
n=571

46.8 (267)

36.6 (209)

13.8 (79)

2.8 (16)

65+ (Retired) n=684

60.4 (413)

30.4 (208)

8.2 (56)

1.0(7)

Data taken from the Clark County Coroner’s Offiee from 2005 were analyzed
statistically. Each age eategory was examined and the mode of death was analyzed using
ehi-square analysis.
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Question 3 addressed if there is an association between prescription drug use and
mortality. Of all deeedents who died with preseription medications in their toxicology
screenings, aceident-related deaths were most common, followed by those who died of
natural-related deaths. O f all decedents who had depressants and antidepressants in their
toxicology results, accident-related deaths were most common followed by suicides. Of
those who had opioid and morphine derivatives in their toxicology screenings, 68.1%
died of accident-related deaths (Table 18).
Of all those who had prescription medications in their toxieology screenings,
aceident-related deaths (60.4%) were most common, followed by those who died of
natural causes (19.8). Within the antidepressant drug category accident-related deaths
were highest (51.9%) followed by suicides (29.6%). O f all those who died with
cannabinoids, accidents were most prevalent (48.7 %) followed by homicides (21.7%).
Within all depressants, accidental deaths were highest (57.2%) followed by suicides
(22.2%). Of all those who died with ethanol in their toxicology screenings, accidentrelated deaths were highest (41.3%). Among all opioids and morphine derivatives,
accident-related deaths (68.1%).
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Table 18 Prevalence o f mode o f death separated by drug category (within drug

Drug Categories/Mode o f Death

Natural
% (n)

Accident
%(n)

Suicide
%(n)

Homicide
%(n)

0 (0 )

0 (0 )

50.0 (1)

50.0(1)

Analgesics (n=132)

31.8(42)

41.7 (55)

25.0 (33)

1.5 (2)

Antidepressants(n=81)

17.3 (14)

51.9(42)

29.6 (24)

1.2(1)

Cannabinoids (n-189)

14.8 (28)

48.7 (92)

14.8 (28)

21.7(41)

Depressants (n=297)

16.5 (49)

57.2 (170)

22.2 (66)

4.0(12)

0 (0 )

33.3(1)

0 (0 )

66.7 (2)

Ethanol (n=569)

30.4(173)

41.3 (235)

18.3 (104)

10.0 (57)

Inhalants (n=l)

0 (0 )

100.0(1)

0 (0 )

0 (0 )

Opioids and Morphine
Derivatives (n=504)

16.3 (82)

68.1 (343)

13.3 (67)

2.4 (12)

Other Compounds (n=77)

37.7 (29)

46.8 (36)

14.3(11)

1.3 (1)

Over-the-Counter Medications
(n=66)

36.4 (24)

30.3 (20)

27.3(18)

6.1 (4)

Prescription Medications
(n=207)

19.8(41)

60.4(125)

15.5 (32)

4.3 (9)

Stimulants (n=366)

9.8 (36)

62.0 (227)

12.8 (47)

15.3 (56)

Anabolic Steroids (n=2)

Dissociative Anesthetics (n=3)

Drugs present in decedents were statistieally analyzed using chi- square analysis. Each
drug category was analyzed and the prevalence of drugs present in decedents was
determined within each mode of death.
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CHAPTER 6

DISCUSSION
The major drugs found in postmortem toxicology screenings as well as associations
among age, gender and ethnicity will be discussed in this section. Potential prevention
strategies will also be presented as possible solutions in decreasing the occurrence of
drug-related deaths.

Major Drugs Found in Modes of Death
Antidepressants, depressants and opioid and morphine derivatives (including heroin
metabolites) were not included in the prescription medication category analyzed.
However, all these medications, cumulatively, represented the majority of substances
found in decedents. Thus, as hypothesized, prescription medications were the most
common substances found in all decedents who died in Clark County, Nevada in 2005.
The high number of prescription drugs found in decedents could be a result of over
prescribing medications from physicians as well as the fact that Internet prescribing is a
common way of accessing medications for the general population (Henney & Shuren,
2000). In order to help overcome this problem of prescription medications potentially
leading to death, future research should be examined this issue in order to change policies
and laws in regards to doctors who write prescriptions on the Internet, as well as to those
Internet sites, which allow purchase of prescription drugs. This could help in preventing
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unfortunate instances from occurring, such as prescription drug overdose leading to
death. In order to prevent unintentional drug-related overdoes, counselors, drug
rehabilitation centers and family members of people with substance use problems need to
be aware that prescription drugs are highly prevalent within decedents in Clark County.
After examining the amount of prescription drugs found in decedents, the results
indicate that we should consider changing policies for physicians in prescribing refills on
medications, which have the potential for addiction (e.g. hydrocodone, methadone,
benzodiazepines). Although, the research conducted did not examine whether or not it
was prescription refills found in decedents, changing policies for how many prescription
refills are allocated to individuals may help in taking unused medieations off the shelves
of potential substance users. Another way to prevent prescription medications from being
abused or sold on the streets would be to have a place for people to return unused
medications so that they can be properly destroyed.
As the literature suggests, ethanol alone represented the most common substance
found in all four modes of death (Inaba & Cohen, 2004). However, the data analyzed did
not take into consideration that decomposing bodies emit a certain percentage of ethanol
after death. This may bias the results and could be a reason for the high numbers of
ethanol found in the decedents (O’Neal & Poklis, 1996). Further research as to how much
ethanol is common in decomposing bodies could be beneficial to future projects related
to death and postmortem toxicology screenings.
Owing to the high representation of ethanol found among decedents in Clark County,
programs such as Mothers Against Drunk Driving (MADD), the Nevada National Guard
Counterdrug Taskforce and Drug Abuse Resistant Education (DARE) need to be aware
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of how many adolescents are dying with ethanol in their bodies. These anti-drug
programs can potentially help in further educating adolescents about the importance of
abstinence from drugs and alcohol. Mass Media sueh as advertisements on the radio and
television, as well as in newspapers and magazines can help in informing the public of
the alarming statisties related to ethanol and death.
Of all decedents who died o f homieide-related deaths, 3.6% of them had both
benzoyleegonine (a metabolite o f cocaine) and ethanol in their toxicology results. The
combination of these two substances can form cocaethylene. As mentioned in the
literature review, the presence of coeaethylene can lead to more violent behavior than
cocaine or ethanol alone (Inaba & Cohen, 2004). This explains why those who had both
benzoyleegonine and ethanol in their toxieology screenings died as a result of homieide.

Aleohol and Motor Vehiele Fatalities
Consistent with the literature, aleohol was the most prevalent substance found in
motor vehicle fatalities (Kelly et al., 2004). The next most eommon substances found in
motor vehicle aceidents were cannabinoids and stimulants. From the data, it is obvious
that there is not only a high correlation between alcohol and motor vehicle fatalities, but
there is also a signifieant relationship between alcohol and all modes of death, weather it
be natural-related causes or those that resulted from homicides. Analyses suggested that
one out of every four motor vehiele fatalities in Clark County involved alcohol. Law
makers should therefore eonsider implementing harsher sentences on those who drive
under the influence. Public health professionals sueh as university educators, counselors
and physicians need to educate the public, especially those who are most vulnerable (i.e.
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teenagers and college-age individuals) about the deleterious effects alcohol can have on
one’s life.
Assistance from restaurants and bars can also help in avoidance of drunk drivers
being on the streets. Phone numbers of taxi services posted on signs within these facilities
may help those who are intoxicated to take a cab home after a night of drinking. Also,
volunteer programs designed to drive intoxicated individuals home during peak drinking
hours could also be beneficial in avoiding fatalities related to ethanol abuse.
Cannabinoids should also be screened for once someone is brought to jail after being
charged with drunk driving. If such drugs are found upon testing, harsher sentences
should be given. This could also be implemented against people who are found with other
drugs such as stimulants, opioids and depressants.

Prevalence o f Drugs Found in Age, Gender and Ethnicity
Age
Of all substances, ethanol and eannabinoids were most prevalent in the toxicology
screening of teenagers. This suggests that anti-drug programs such a DARE and MADD
need to be not only aware o f these statistics, but also need to address people within this
age group. Individuals within such age categories may be more susceptible to peerpressure and rebellious behavior and therefore attention needs to be focused upon
teenagers in order to help prevent drug-related fatalities (Gottfredson & Koper, 1996).
Gender
Of all decedents, there was a higher prevalenee of all substances found in males.
Owing to the fact that males often engage in more rebellious and risky behaviors than
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females, the findings of more drug substances in males, is not surprising (Gottfredson &
Koper, 1996). However, females were more likely to have prescription medications
including antidepressants, depressants and opioid and morphine derivatives than males.
When looking at male decedents, there was a higher prevalenee of ethanol, cannabinoids
and stimulants than in females. Programs sueh as DARE, MADD and the National Guard
Counterdrug Taskforce could design classes which focus on preventing males and
females from becoming substance abusers with drugs they are more susceptible in using.
The fact that teenagers (aged 12-17) were more likely to have ethanol and cannabinoids
in their toxicology screenings also suggests that the anti-drug programs may have failed
in reaching these individuals. This indieates that anti-drug programs should consider
changing their programs in order to better address adoleseents and substance abuse.
Ethnicitv
Caucasians represented the majority of all decedents. Of all African Americans,
Asians and Hispanics, ethanol was the most prevalent substance found, while opioids and
morphine derivative were most commonly found in Caucasians. Statistically, it was
found that Caucasians were most likely to have substances such as prescription
medications in their toxicology screenings, while Affiean Amerieans and Hispanies were
more likely to have substances such as Stimulants and Cannabinoids in their toxicology
screenings upon death. Thus, as hypothesized, there is a difference in substance abuse
among ethnicity. Owing to these faets, eourses or programs designed for speeific cultures
or ethnieities could help educate those who are at risk for drug-related mortality.
Aecording to the US Census Bureau, nearly a quarter of Nevada’s population in 2005
consisted o f Hispanics (US Census Bureau, 2005). There is a potential language barrier
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among this group of individuals. Coordinating programs that are designed for those who
are not proficient with the English language could be beneficial in educating not only
Hispanics, but also other ethnicities and cultures about drug-related mortalities.

Accidents, Homicides and Children
As hypothesized, accident and homicide-related deaths were the top two leading
causes of death among toddlers (aged 1-4) and those in childhood years (aged 5-11). It is
important that parents and law enforcement personnel in Clark County, Nevada are aware
of the alarming statistics among homicides and accident-related deaths in children.
Parents need to be more cautious when leaving their children unattended for any period
of time, and lawmakers should consider changing the policies that are enforced against
parents with any kind o f domestic violence history. This can help prevent those who are
unsuitable for parenthood to either put their children up for adoption or even find help in
treating their problems. Such alternatives can furthermore prevent children from the risks
o f domestic violence and homieide. Also, implementing higher fines or jail sentences
against parents who are caught driving recklessly with children could also help in
preventing accidents among children. Educating and informing day care facilities and
pre-school workers about the signs of child abuse can also help in preventing homicides
among young children. Posting phone numbers of domestic violence hotlines such as
S.A.F.E. House or Safe Nest within child day care facilities for circumstances where
abuse is suspected may also help in addressing violence against children who are
vulnerable. Children should also be aware of what abuse is and know how to approach a
teacher or nanny if they are being abused by their parents. Lectures in elementary schools
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or pre-schools could educate younger children about the difference between a spanking
and an unnecessary beating.

Prescription Drugs and Mortality
Prescription drugs (including antidepressants, depressants and opioid and morphine
derivatives) represented the majority of substances found in all decedents. Whether or not
these drugs led do the demise o f the decedents, there is obviously a significant
association among prescription drugs and death. Future research considering policy
changes could potentially help prevent the abuse of prescription drugs. Education,
intervention and monitoring of prescription drugs are a few prevention strategies, which
could be useful in order to control the “epidemic” of prescription drugs. Illicit abuse of
prescription drugs can lead to precarious events such as crime, homicide, suicide and
death resulting from accidental overdoses. Informing the public about the statistics when
it comes to deaths related to prescription drug abuse is important in the prevention of
serious public health issues. Substituting commonly abused prescription drugs such as
methadone for buprenorphine also may help in preventing potential problems with
pharmacotherapeutic drugs (Jones, 2004). Knowing the statistics relating to the abuse of
prescription drugs will furthermore help encourage public health workers to target highrisk groups for prevention and treatment programs.
Ethanol represented the majority of substances found within the elderly (aged 65+)
followed by opioid and morphine derivatives and depressants. Owing to the fact that
prescription medications and depressants were among the top three most common
substances found in decedents, it is obvious that prescription medications are a problem
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among the elderly (aged 65+). Not only can these drugs be misused and abused, but they
may also lead to death if not taken as directed. Because the elderly (aged 65+) are closer
to death and suffering from more ailments than the rest of the population, they may be
more susceptible to taking a few extra depressants in order to end their lives too soon.
Physicians need to be aware o f the fact that there is a significant statistical correlation
between elderly (aged 65+) death and prescription medications. Thus, future research
should look at changing policies related to the possibility of over-prescribing medications
to the elderly (aged 65+).

Research Limitations
The lack of all concentrations of drug substances prevented pharmacokinetic models
from being considered. However, alcohol, cocaine and heroin were all quantified and
could be of use for further studies to examine concentrations of drugs found within
decedents.
At the time the data were collected, some of the causes of death were pending or
undetermined. A separate study could be conducted with these data to see if there are
associations between undetermined deaths and drugs. As mentioned earlier, ethanol is
common in decomposing bodies. Further research, which would take into consideration
the exact amounts of ethanol in decomposing bodies released upon death, could also be
examined in future studies.
Although ethanol and motor vehicle fatalities were examined in this study, it was not
noted whether or not the decedent was the driver of the car, or a passenger who happened
to be intoxicated at the time of death. Therefore, future research could examine if it was
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indeed ethanol which led to the motor vehicle fatality and provide a more accurate study
relating to motor vehicle deaths and ethanol.
Examining the environment of each decedent could have also been beneficial to this
study. This can furthermore help in determining the relationship of manners of death and
the different substances detected in particular demographic areas of Clark County.
Another limitation is that some of the decedents may have been visiting an area in
Clark County at the time of their death. Although they may have actually lived in another
state or county, they were examined at the Clark County, Coroner’s office. Furthermore,
this may bias the results. Therefore looking into the deaths of people who were residents
of only Clark County may provide a more accurate study when examining associations of
drugs and death.
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CHAPTER 7

SUMMARY
This project demonstrated that drugs, whether they be prescription medications, overthe counter medications, or illicit substances, may not always be directly associated with
deaths in Clark County, but that there is a significant relationship among drug use and
death. Previous research and studies have supported these findings; however, after
analyzing the data of prescription medications and ethanol in different modes of death, it
is obvious that there is a problem with drug use leading to death, which needs to be
addressed.
This study was the first report of drug-related mortalities conducted in Clark County,
Nevada. It is important to inform the public of the associations between ethnicity, age,
gender and toxicological findings in different modes of death. Furthermore, examining
the years prior to 2005 should also be conducted in order to analyze potential trends in
drug-related mortality.
The public needs to not only be aware of the facts related to drugs and death, but
action also needs to be taken in order to prevent drug-related mortality. Further research
should look at changing policies, laws and education practices in order to help decrease
the prevalence o f drugs found in not only postmortem decedents, but also help prevent
abuse in those who are living. The findings from this research complimented previous
studies related to drug use, and also showed statistics about death and mortality that have
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not been studied to this date. It is important that research continues to be done in regards
to mortality and drugs in order to address substance abuse and help prevent unfortunate
circumstances from occurring within Clark County, Nevada.
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APPENDIX I

ANTIDEPRESSANTS

Common/”street’V
BRAND NAME
Amitriptyline,
ELAVIL®,
TRYPTANOL®,
ENDEP®,
TRYPTIZOL®

CHEMICAL NAME

‘STRUCTURE

3-(l 0,11 -dihydro-5H-dibenzo[a,d]
cyclobeptene-5 -ylidene)-N, Ndimetbyl-1-propanamine
c

G

c

)

k ^ .C H 3
1

CH3
b
Bupropion,
WELLBUTRIN®

(±)-1-(3 -cbloropbenyl)2-[(l, 1-dimetbyletbyl)amino]1-propanone

ÇrVv
Cl

b

’ a-PDR (Physicians Desk Reference); b-www.emolecnles.com
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Citalopram,
CELEXA®

Cyclobenzaprine,
FLEXERIL®

(±)-1-(3 -dimethylaminopropyl)1-(4-fluorophenyl)-1,3dihydroisobenzofuran-5carbonitrile, HBr

/

-CHa

CH2CH2CH2N

\

•HBr

'CHa

3-(5 H -dibenzo[ a,d ]
cyclohepten-5 -ylidene)N , N -dimethyl-1-propanamine
hydrochloride

HCCH2CH2N(CH3)2'HCI

Desipramine,
NORPRAMIN®,
PERTOFRANE®

Desipramine

Doxepin,
APONAL®

1l-(3-(Dimethylamino)
propylidene)-6Hdibenz(b,e)oxepine

H 3C

C H 3
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Escitalopram,
LEXAPRO®

S-(+)-1-[3-(dimethylamino)propyl]-l-( p fluorophenyl)-5phthalancarbonitrile oxalate

NC. /V

yn r
«cm

T
F

a
Fluoxetine,
PROZAC®

(±)-N-methyl-3-phenyl-3[((alpha),(alpha),(alpha)trifluoro- p tolyl)oxy]propylamine
hydrochloride

FjC-^^-O-CHCHaCHsNHCHs . HCI

è
a

Imipramine,
ANTIDEPRIN®,
JANMINE®,
TOFRANIL®

Impramine
Hydrochloride

y
1

Mirtazapine,
REMERON®

b

1,2,3,4,10,14bhexahydro-2methylpyrazino[2,l-a] pyrido
[2,3-c]
henzazepine

CHa

b
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Nortriptyline,
AVENTYL®,
PAMELOR®

3-(10,ll-dihydro-5Hdibenzo[a,d]
cyclohepten-5-ylidene)- Nmethyl-1propanamine

0yO
H

b
Paroxetine,
PAXIL CR®

(3S-trans)-3-((l ,3-Benzodioxol5-yloxy)methyl)- 4-(4fluorophenyl)-piperidine
hydrochloride

H

F

b
Sertraline,
ZOLOFT®

( 1S-cis)-4-(3,4-dichlorophenyl)1,2,3,4-tetrahydro-N-methyl-1naphthalenamine hydrochloride

Cl

b
Trazodone,
DESYREL®

8-[3-[4-(3chlorophenyl)piperazin
-l-yl]propyl]-6,8,9triazabicyclo[4.3.0]
nona-2,4,9-trien-7-one

D

b
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Venlafaxine,
EFFEXOR®

(R/S)-1-[2-(dimethylamino)-1
(4-methoxyphenyl)ethyl]
cyclohexanol hydrochloride

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

OH

APPENDIX II

DEPRESSANTS

Common/”street’7
CHEMICAL NAME
BRAND NAME
’Alprazolam,
8-chloro-1-methyI-6phenyl-4 H-s XANAX XR®
triazolo [4,3-(alpha)j [1,4]
benzodiazepine

'STRUCTURE

Æ

M l
^Antihistamine

Hi-receptor
Antagonists
X-| Spacer -N
R2
b

* a-PDR (Physicians Desk Reference); b-www.emolecules.com
* Benzodiazepine Class
^ Diphenhydramine
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Buspirone,
BUSPAR®

N/A
Ity N

?
b
Butalbital,
AXOCET®,
BUCET®,
BUPAP®

5-(2-methylpropyl)5-(2-propenyl)2,4,6(1H,3H,5H)pyrimidinetrione
H ,c ''

Clonazepam,
KLONOPIN®

^Diazepam,
VALIUM®,
SEDUXEN®,
APOZEPAM®

6-(2-chlorophenyl)-9nitro2,5-diazabicyclo
[5.4.0]
undeca5,8,10,12-tetraen-3one
7-chloro-1-methyl5-phenyl-l,3dihydro-2H1,4-benzodiazepin2-one

C

j

0

„

K - / '

H3Ç

xxzf
0

Ethanol

Ethyl alcohol

b

Benzodiazepine Class
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Flunitrazepam,
ROHYPNOL®,
“forget-me pill,”
“Mexican Valium,’
“R2,” “roofies”

6-(2-fluorophenyl)-2methyl-9-nitro2,5-diazabicyclo
[5.4.0]
undeca5,8,10,12-tetraen3-one

Flurazepam,
DALMANE®

7-chloro-1-[2(diethylamino)ethyl]5-( o -fluorophenyl)1.3-dihydro-2 771.4-benzodiazepin2-one di
hydrochloride

GammaHydroxyhutyrate,
“GHB”, Fantasy,
G, Juice, Liquid
Ecstasy, &
Gamma-OH,
XYREM®

4-Hydroxybutanoic
acid

Isopropanol

Isopropyl alcohol

Lorazepam,
ATIVAN®

9-chloro-6-(2chlorophenyl)-4-hydroxy2,5-diazabicyclo[5.4.0]
undeca5,8,10,12-tetraen-3one

CHgCHgNtCaHsk

o
' 2HCI

OH

Benzodiazepine Class
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Meprobamate,
MILTOWN®

Midazolam,
VERSED®,
HYPNOVEL®,
DORMICUM®

[2 -(carbamoyloxy
methyl)-2 -methylpentyl]
carbamate

CH<

A

8 -chloro-6 -(2 -

^
O

0 - <

CH,

CH

fluorophenyl)-!methyl4H-Imidazo(l ,5-a)
(1,4)
benzodiazepine

Oxazepam,
ALEPAM®,
MURELAX®,
SERAX®,
SEREPAX®,
SERESTA®

9-chloro-4hydroxy-6 -phenyl2,5-diazabicyclo
[5.4.0]
undeca5;8,10,12tetraen-3-one

Pentobarbital,
NEMBUTAL®

5-ethyl-5( 1-methylbutyl)
barbiturate

Ci

M.

CH3CH2
CH3CH2CH2CH

CH3
Phénobarbital,
LUMINAL®

NH,

5-ethyl-5-phenyl1,3-diazinane-2,4,6-trione
HN
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JONa

Phenytoin,
DILANTIN®

5,5-diphenyl-2,4imidazolidinedione

Primidone,
MYSOLINE®

5-ethyl-5-phenyl-l ,3diazinane-4,6-dione

_ONa

NH

Temazepam,
RESTORIL®

7-Chloro-1,3-dihydro3-hydroxy-1-methyl5-phenyl1,4-benzodiazepin-2one

Zolpidem,
AMBIEN®

N,N,6-trimethyl-2-ptolylimidazo[ 1,2 -a]
pyridine-3-acetamide L(+)-tartrate (2 : 1)

CH,

coon
H-C-OH
I

HO-C-H
I

N-CH,
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COOH

APPENDIX III

STIMULANTS

Common/”street”
/BRAND NAME
Amphetamine,
BIPHETAMINE®
“speed,” “bennies,”
“black beauties,”
“uppers,” “crosses”

CHEMICAL NAME

"STRUCTURE

1-phenylpropan-2 -amine

CH:
b

[lR-(exo,exo)]-3Cocaine,
(Benzoyloxy)-8 COCAINE
HYDROCHLORIDE® methyl-8 -azabicyclo
[3.2.1]octane-2“crack,”
carboxylic acid methyl
“œ ke”
* Benzoylecgonie
ester

CH.

0

b
Ephedrine

{\R ,25)-2-methylamino1-phenylpropan- 1-ol

H

CH3
b

*”street name” taken from NIDA
** Cocaine metabolite
a-PDR (Physicians Desk Reference); b-www.emolecules.com
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Methamphetamine,
DESOXYN®,
“crystal,” “crank,”
“ice,” “meth,”
“speed”

(S)-N-methyl-1-phenylpropan-2 -amine

*Methylenedioxymet
hamphetamine
,MDMA, “ecstacy”,
“E”'
“xfc", “X", “Adam"

1-(benzo[d][l,3]dioxol5-yl)-N-methylpropan2 -amine

Methylenedioxyamph
etamine, MDA

3,4-methylene
dioxyamphetamine

Phentermine,
ADIPREX-P®,
OBENIX®,
OBY-TRIM®

(alpha),(alpha)-Dimethyl
phenethylamine
hydrochloride

NH CHa

CHa

ÇH3
C1@H15N.HCI

CHgC—NH? • HCI

*"street names” taken from NIDA
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CH3

APPENDIX IV

OPIOIDS AND MORPHINE DERIVATIVES

Common/”street’7
BRAND NAME
Codeine,
ROBITUSSIN AC®, "cody,"
“Captain Cody”

CHEMICAL NAME

'STRUCTURE

7,8-didehydro-4,5-epoxy3-methoxy-17methyImorphinan-6 -ol

HO'
a
Fentanyl,
DURAGESIC®

N-Phenyl-N-( I -(2-phenylethyl) CH,OH,CON—^
4-piperidinyl) propanamide

CH,CH;-^~^

**Hydrocodone,
VICODIN®,
ANEXIA®,
LORCET®,
LORTAB®, “vike,”
“Watson-387”

4,5 a-Epoxy-3 -methoxy-17methylmorphinan-6 -one
tartrate (1:1) hydrate (2:5)

WCH)

Ô

CH3O

0

0

a

a-PDR (Physicians Desk Reference); b-www.emolecnles.com
* Street names taken from NIDA
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Methadone,
DOLOPHINE®

6-(dimethylamino)-4,4diphenyl-3 -heptanone

1

b
Meperidine/Pethidine,
Ethyl-1-methyl-4ALGIL®’
phenylpiperidine-4DEMEROL®
carboxylate

N—
0

b
**Morphine,
ROXANOL®, “M,”
“Miss Emma,”
“monkey”
***Heroin

7,8-didehydro4,5-epoxy-17methylmorphinan-3,6 -diol

\l

a
Nalbuphine,
NUBAIN®

(-)-17-(cyclobutylmethyl)-4,
5alpha-epoxymorphinan3,6alpha,14-triol hydrochloride

0

HO... i

a
Opiates (morphine,
codeine)
**Oxycodone,
OXYCONTIN®
“Oxy," “O.C.,”
“killer”

See morphine/codeine

See morphine/codeine

4, 5-epoxy-14-hydroxy-3 methoxy-17-methylmorphinanone

CHjO

°

Q
a

''a-PDR (Physician’s Desk Reference); b-www.emolecules.com
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Oxymorphone,
NUMORPHAN®

CHg

4.5a-Epoxy-3,14-dihydroxy17-methylmorphinan

1

N ^C H g

OH

0

°

a
Propoxyphene

Ethyl-1-methyl-4phenylpiperidine-4-carboxylate

0
1

CM
, OCCA

W

l #W—Ç—C—

' H
iO

'Ô
b

Street names taken from NIDA
*** Narcotic derived from Morphine (6 -Monoacetylmorphine-metabolite of heroin)
86

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX V

ANALGESICS

Common/”street”/BRAND
CHEMICAL NAME
NAME
Acetaminophen/Paracetamol, N-(4-hydroxyphenyl)
acetamide
TYLENOL®, MIDOL®

'STRUCTURE

H

H
Hydromorphone,
DILAUDID®

c r ^

4,5-o:-epoxy-3hydroxy 17 -methylmorphinan-6 -one

^

ÏSICH3

HO
Ibuprofen,
ACT3®,ADVIL®,
BRUFEN®,
NUPRIN®

°

0

0

a

2-[4-(2methylpropyl)
phenyljpropanoic
acid

a
Ketorlac, TORADOL®

(±)- 5-benzoyl-2,3dihydrolH-pyrrolizine-1carboxylic acid,
2 -amino-2 (hydroxymethyl)1 ,3-propanediol

C Jj

a-PDR (Physician’s Desk Reference); b-www.emolecules.com
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OH
a

Naproxen

(S)-6 -methoxy-o!methyI-2 naphthaleneacetic
acid

CH,

•O P
a

Salicylate/Salicylic acid

2 -hydroxybenzoic

acid

0

b
Tramadol, ULTRAM®

rac-{\R,2R)-l(dimethylamino
methyl)-1(3 -methoxyphenyl)cyclohexanol
CH,

b
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APPENDIX VI

OTC/PRESCRIPTION MEDICATIONS

Common/”street”/
BRAND NAME
Albuterol,
PROVENTIL®

* Carbamazepine,
CARBATROL®

CHEMICAL NAME
(alpha) ‘ -[( tert butylamino) methyl]4hydroxy- m -xylene(alpha), (alpha)'-diol)
5H-dibenz(b,f)
azepine-5carboxamide

'STRUCTURE
HOCHav^___
HO - < ( 3 /

CHCHgNHC(CH3)3
OH
a

a
Carisoprodol,
SOMA®

CH,

N-isopropyl-2-methyl2-propyl-l,3propanediol
dicarbamate
k, c^

Chlorphenamine,
Chlor-Trimeton®

Clyclobenzaprine
HCL, FLEXERIL®

(3RS)-3-(4chlorophenyl)N,N-dimethyl3-(pyridin-2yl)propan-Iamine

,

h

ÇH,
H^c''

'y

V

3-(5 H -dibenzo[ a,d'\
cyclohepten-5 -ylidene)
V , A-dimethyl-1propanamine
hydrochloride

II

HCCH2CH2N(CH3)2 • HCI

a-PDR (Physician’s Desk Reference); b-www.emolecules.com
* 10-Hydroxycarbazepine-metabolite of carbamazepine
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Colchicine,
COLCHICINE®

Dextromethorphan,
DM®, DXM®

N-((7S)-5,6,7,9tetrahydro1,2,3,10-tetramethoxyoxobenzo(a)
heptalen-7-yI)acetamide
D-(+)-3methoxy-17-methyl(9a, 130,14a)morphinan

_

H 0

CM.-0

C K -0

H3CO

CM
H

Dicyclomine,
BENTYL®

[bicyclohexyl]-Icarboxylic acid,
2 -(diethylamino)
ethylester

CHa—CH3
C — O — C H a— CH a— N

CHa— CH3

Digoxin, DIGITEK®

3-((0-2,6-dideoxy-j3D-ribo-hexopyranosyl( 1-4)-0-2,6-dideoxy|3-Dribo-hexopyranosyl(l-4)-2,6dideoxy-/3-Dribo-hexopyranosyl)
oxy)12,14-dihydroxy,(3|8,5,8,12i8)card-20(22)enolide
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c-H

Diltiazem,
CARDIZEM®

[2 -(2 -dimethyl
aminoethyl)5-(4-methoxyphenyl)
-3-oxo-6-thia-2azabicyclo
[5.4.0]undeca7,9,
1l-trien-4-yl]ethanoate

Diphenhydramine,
BENADRYL®

2-(Diphenyl
methoxy) N,N-dimethyl
ethylamine
hydrochloride

Diphenoxylate,
Lomotil®

ethyl l-(3-cyano-3,3diphenyl-propyl)- 4phenylpiperidine-4carboxylate

Disulfiram,
ANTABUSE®

Bis(diethylthio
carbamoyl) disulfide

Doxylamine,
UNISOM®
NIGHTTIME SLEEP
AID

N/A

AX,

S

S

II

II

(CgHglaNC — S — S — CN(CaHs)2

A
/

N—
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(S)-1-[N-[I(ethoxycarbonyl)-3 phenylpropyl] -1aIanyl]-l-proIine

Enalapril,
RENITEC®,
VASOTEC®

H

EtOOC.
^
1

?
A.
cHg y L y
HOOC

b
(±)-4-[ly=\
hydroxy-4-[4w
(hydroxy
diphenylmethyl) - 1H0 -)—(
piperidinyl]butyl]-(alpha), (alpha)dimethyl
benzeneacetic
acid

Fexofenadine,
ALLEGRA®

A i
N

Y

a
Gabapentin,
NEURONTIN®

■

l-(aminomethyl)cyclohexane
acetic acid
\ ___ A

CHgCOgH
a

Hydroxyzine,
ATARAX®,
UCERAX®,
SERECID®

l-(pchlorobenzhydryl) 4[2-(2 hydroxyethoxy)ethyl] piperazine

Levetiracetam,
KEPPRA®

(-)-(S)-a-ethyl-2-oxoI-pyrrolidine
acetamide

Lithium,
ESKALITH®

Li

b

^
N/A

^
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b

Meprobamate,
MILTOWN®

Methocarbamol,
ROEWJON®,
ROBAXACET®,
ROBAX
PLATINUM®
Olanzapine,
ZYPREXA®,
SYMBYAX®

[2 -(carbamoyl
oxy
methyl)-2 methyl-pentyl]
carbamate

k OCONHa

b

[2-hydroxy-3(2 -[2 methoxy
phenoxy)-propyl]
aminoformate

N/A

2-methyl-4-(4-methylI-piperazinyl)lOH-thieno
[2,3-b][I,5]
benzodiazepine

o
b

Phendimetrazine,
BONTRIL®

3,4-Dimethyl-2phenylmorpholine

Pheneytoin,
DILANTIN®

5,5-diphenyl-2,4imidazolidine
dione

b
N -/

V

^

Phenmetrazine,
PRELUDIN®

3-methyl-2pheny
Imorpholine

O

Phenylpropanolamine

2 -amino-1 -pheny-1-

OH

b

b
propanol

OT"’
b
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Procainamide,
PRONESTYL®,
PROCAN®,
PROCANBID®

4-amino-N- (2 -diethyl
aminoethyl)
benzamide
structure taken from:
http://redpoll.pharmacy.ualberta.ca/
drugbank/index .html____________

Prochlorperazine,
COMPAZINE®,
BUCCASTEM®,
STEMETIL®

2 -chloro-lO-

[3-(4-methyl-lpiperazinyl)
propyl]lOH-phenothiazine (Z)
-2 -butenedioate

Cl

structure taken from:
http://bibleocean.com/OmniDefinition/
Prochlorperazine__________________
Promethazine,
PHENERGAN®

N, N,alpha-trimethyl1OH-phenothiazine10-ethanamine (9CI)

Pseudoephedrine,
SUDAFED®

(l^ , 2 ^ - 2 methylamino1-phenylpropanl-ol

Quetiapine,
SEROQUEL®

2-[2-(4-dibenzo
[ b,f] [I,4]thiazepin11 -yl- 1 -piperazinyl)
ethoxyj-ethanol
fumarate (2 : 1) (salt)

HN+

0—

'

' N-Acetylprocainamide-metabolite of Procainamide
' Norpseudoephedrine-pseudoephedrine metabolite
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Risperidone
"RISPERDAL®

Secobarbital,
SECONAL®

4-[2-[4-(6-fluorobenzo
[d]isoxazol-3-yl)1-piperidyl]ethyl]-3methyl2 ,6 -diazabicyclo
[4.4.0]deca-l,3-dien-5one
5-(I -methylbutyl)-5prop-2 -enylhexahydro
pyrimidine2,4,6-trione

a

b

0

Sildenafil, VIAGRA® l-[4-ethoxy-3(6,7-dihydro-lmethyl7 -O X O -3 -

propyl-I/7pyrazolo[4,3rdpyrimidin-5-yl)
phenylsulfonyl]4-methyl
piperazine citrate
a
Theophylline
THEO-DUR®,
RESPBID®,
SLO-BID®

0

I,3-dimethyl-7Hpurine-2 ,6 -dione

>

1

b
Topiramate,
TOPAMAX®

2,3:4,5-D i-0isopropylidene-(beta)D-fructopyranose
sulfamate

J— 0
9 ....\
H3C

PH 2OSO2 NH2

y ^ o
CHa
a

9-Hydroxyrisperidone-metabolite of risperidone
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Valproic Acid,
DEPAKENE®

2 -propyl
pentanoic acid

CMg-CHg-CHgv

0

CH3 —CH2—C H /

OH
a

Verapamil,
ISOPTIN®,
VERELAN®,
CALAN®

2-(3,4-dimethoxy
phenyl)-5[2-(3,4dimethoxy
phenyl)ethyl-methylamino]
-2 -(l-methy
lethyl)
pentanenitrile

Ziprasidone,
GEODON®

5-[2-[4-(l,2benzisothiazol-3-yl)-1 piperazinyl]
etbyl]
6 -chloro-l ,3-dihydro-2
- indol-2 -one

b

C y,
b

Zolpidem, AMBIEM® N,N,6 -trimethyl2-(4-methylphenyl)imidazo(l ,2 -a)pyridine
3-acetamide

/(-CM,
M,C
b

Zonisamide,
ZONEGRAN®

1 ,2 benzisoxazole-3methane
sulfonamide

yN

C H 2S 0 2 N H 2 ,
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APPENDIX VII

DISOCIATIVE ANESTHETICS

Common/”street”/BRAND
NAME
Ketamine, KETANEST®,
KETASET®, and
KETALAR®, “Special K,”
“K,” “Vitamin K,”
“Cat Valium”
Phencyclidine, "PCP", “Angel
Dust”, “sherm”

CHEMICAL NAME

STRUCTURE

2 -(2 -chlorophenyl)2 -(methylamino)-

cyclohexanone

Phencyclidine

b-www. emolecules.com
* “street names” taken from NIDA
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APPENDIX VIII

CANNABINOIDS

Common/”street’7BRAND
NAME
**Cannibis, “hash,”
“chronic,” MARINOL®

CHEMICAL NAME

"STRUCTURE

Delta-9tetrahydrocannabinol
OH

1

^

b

b-www. emolecules.com
* “street names” taken from NIDA
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APPENDIX IX

ANABOLIC STEROIDS

Common/”street”/BRAND
NAME
Boldenone,EQUIPOISE®,
GANABOL®,
EQUIGAN®

CHEMICAL NAME

STRUCTURE

1,4-androstadieene-3one,17|8-ol

Nandrolone, DEC ADURABOLIN®

17(8-Hydroxyestra-4en-3-one

Stanozolol,WINSTROL®

17|8-Hydroxy-17methyl5a -androstano[3,2-c]
pyrazole

b-www.emolecules. com
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APPENDIX X

OTHER COMPOUNDS
’STRUCTURE

COMMON/”street’V CHEMICAL NAME
BRAND NAME
Acetone
|8-ketopropane,
Dimethyl ketone

O

A
Arsenic

Arsenic

Bupivacaine,
MARCAIN®,
MARCAINE®,
SENSORCAINE®

l-butyl-A-(2 ,6 dimethylphenyl)
piperidine-2 carboxamide

h

As

b
Carbon Monoxide

Carbon Monoxide

Carboxyhemoglobin N/A
Cyanide
hydrogen cyanide,
cyanogen chloride,
sodium cyanide,
potassium cyanide
Ethylene Glycol
Ethane-1,2-diol

CO
COHb
HCN, CNCl, NaCN, KCN

.O H
HO

b

b-www.emolecules.com
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Ketamine,
KETANEST®,
KETASET®,
KETALAR®

2 -(2 -chlorophenyl)2 -(methylamino)-

Ketones

Ketone group

Lamotrigine,
LAMICTAL®

3,5-diamino-6-(2,3dichlorophenyl)-astriazine

cyclohexanone

Vi
n

L xpL

Cf
Cl

Lead
Lidocaine,
LIGNOCAINE®

Mercury
Strychnine

Pb
N/A
acetamide, 2 (diethylamino)-N(2 ,6 -dimethylphenyl)

N/A
Strychnos nuxvomica

/
N H - C O - C H 2 - K1
\

Hg

b-www.emolecules.com
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C,H
2*^5
CoH
2^5
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